Oxidoreductive	O
regulation	O
of	O
nuclear	B-protein
factor	I-protein
kappa	I-protein
B	I-protein
.	O

Involvement	O
of	O
a	O
cellular	O
reducing	O
catalyst	O
thioredoxin	B-protein
.	O

We	O
have	O
investigated	O
an	O
oxidoreductive	O
regulatory	O
pathway	O
for	O
the	O
DNA	O
binding	O
activity	O
of	O
a	O
pleiotropic	B-protein
cellular	I-protein
transcription	I-protein
factor	I-protein
,	O
nuclear	B-protein
factor	I-protein
kappa	I-protein
B	I-protein
(	O
NF	B-protein
kappa	I-protein
B	I-protein
)	O
,	O
has	O
been	O
investigated	O
by	O
using	O
NF	B-protein
kappa	I-protein
B	I-protein
prepared	O
from	O
the	O
nucleus	O
and	O
the	O
cytosol	O
of	O
the	O
primary	B-cell_type
human	I-cell_type
T	I-cell_type
lymphocytes	I-cell_type
.	O

We	O
show	O
that	O
a	O
cellular	O
reducing	O
catalyst	O
thioredoxin	B-protein
(	O
Trx	B-protein
)	O
plays	O
a	O
major	O
role	O
in	O
activation	O
of	O
the	O
DNA	O
binding	O
of	O
NF	B-protein
kappa	I-protein
B	I-protein
in	O
vitro	O
and	O
stimulation	O
of	O
transcription	O
from	O
the	O
NF	B-protein
kappa	I-protein
B	I-protein
-dependent	O
gene	O
expression	O
.	O

We	O
demonstrate	O
evidence	O
suggesting	O
that	O
redox	O
regulation	O
of	O
NF	B-protein
kappa	I-protein
B	I-protein
by	O
Trx	B-protein
might	O
be	O
exerted	O
at	O
a	O
step	O
after	O
dissociation	O
of	O
the	O
inhibitory	O
molecule	O
I	B-protein
kappa	I-protein
B	I-protein
,	O
a	O
cytosolic-anchoring	B-protein
protein	I-protein
for	O
NF	B-protein
kappa	I-protein
B	I-protein
.	O

To	O
examine	O
the	O
effect	O
of	O
Trx	B-protein
in	O
intact	O
cells	O
,	O
we	O
performed	O
transient	O
assay	O
with	O
a	O
chloramphenicol	B-DNA
acetyltransferase-expressing	I-DNA
plasmid	I-DNA
under	O
the	O
control	O
of	O
human	B-DNA
immunodeficiency	I-DNA
virus	I-DNA
(	I-DNA
HIV	I-DNA
)	I-DNA
long	I-DNA
terminal	I-DNA
repeat	I-DNA
and	O
an	O
effector	B-DNA
plasmid	I-DNA
expressing	O
human	B-protein
Trx	I-protein
.	O

The	O
promoter	O
activity	O
from	O
HIV	B-DNA
long	I-DNA
terminal	I-DNA
repeat	I-DNA
was	O
greatly	O
augmented	O
by	O
co-transfecting	O
the	O
Trx-expressing	B-DNA
plasmid	I-DNA
,	O
whose	O
effect	O
was	O
dependent	O
on	O
the	O
NF	B-protein
kappa	I-protein
B	I-protein
-binding	O
sites	O
.	O

These	O
findings	O
have	O
suggested	O
that	O
cysteine	O
residue	O
(	O
s	O
)	O
of	O
NF	B-protein
kappa	I-protein
B	I-protein
might	O
be	O
involved	O
in	O
the	O
DNA-recognition	O
by	O
NF	B-protein
kappa	I-protein
B	I-protein
and	O
that	O
the	O
redox	O
control	O
mechanism	O
mediated	O
by	O
Trx	B-protein
might	O
have	O
a	O
regulatory	O
role	O
in	O
the	O
NF	B-protein
kappa	I-protein
B	I-protein
-mediated	O
gene	O
expression	O
.	O

These	O
results	O
may	O
also	O
provide	O
a	O
clue	O
to	O
understanding	O
of	O
the	O
molecular	O
process	O
of	O
AIDS	O
pathogenesis	O
and	O
its	O
possible	O
biochemical	O
intervention	O
.	O

THE	NULL
JOURNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©1993	NULL
by	NULL
The	NULL
Ameri	NULL
Society	NULL
for	NULL
Bioch	NULL
1	NULL
istry	NULL
and	NULL
Mol	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

268	NULL
,	NULL
No	NULL
.	NULL

15	NULL
,	NULL
Issue	NULL
of	NULL
May	NULL
25	NULL
,	NULL
pp	NULL
.	NULL

11380-11388	NULL
,	NULL
1993	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Oxidoreductive	NULL
Regulation	NULL
of	NULL
Nuclear	NULL
Factor	NULL
«	NULL
k	NULL
B	NULL
INVOLVEMENT	NULL
OF	NULL
A	NULL
CELLULAR	NULL
REDUCING	NULL
CATALYST	NULL
THIOREDOXIN®*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
October	NULL
26	NULL
,	NULL
1992	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
January	NULL
5	NULL
,	NULL
1993	NULL
)	NULL
Takuma	NULL
Hayashit§	NULL
!	NULL

,	NULL
Yoshio	NULL
Ueno§	NULL
,	NULL
and	NULL
Takashi	NULL
Okamotot|	NULL
From	NULL
the	NULL
{	NULL
Virology	NULL
Division	NULL
,	NULL
National	NULL
Cancer	NULL
Center	NULL
Research	NULL
Institute	NULL
,	NULL
5-1-1	NULL
Tsukiji	NULL
,	NULL
Chuo-ku	NULL
,	NULL
Tokyo	NULL
104	NULL
,	NULL
Japan	NULL
and	NULL
the	NULL
§Faculty	NULL
of	NULL
Pharmaceutical	NULL
Science	NULL
,	NULL
Science	NULL
University	NULL
of	NULL
Tokyo	NULL
,	NULL
12	NULL
Ichigaya-Funakawaramachi	NULL
,	NULL
Shinjuku-ku	NULL
,	NULL
Tokyo	NULL
162	NULL
,	NULL
Japan	NULL
We	NULL
have	NULL
investigated	NULL
an	NULL
oxidoreductive	NULL
regulatory	NULL
pathway	NULL
for	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
a	NULL
pleiotropic	NULL
cellular	NULL
transcription	NULL
factor	NULL
,	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
(	NULL
NF	NULL
«	NULL
B	NULL
)	NULL
,	NULL
has	NULL
been	NULL
investigated	NULL
by	NULL
using	NULL
NFB	NULL
prepared	NULL
from	NULL
the	NULL
nucleus	NULL
and	NULL
the	NULL
cytosol	NULL
of	NULL
the	NULL
primary	NULL
human	NULL
T	NULL
lymphocytes	NULL
,	NULL
We	NULL
show	NULL
that	NULL
a	NULL
cellular	NULL
reducing	NULL
catalyst	NULL
thioredoxin	NULL
(	NULL
Trx	NULL
)	NULL
plays	NULL
a	NULL
major	NULL
role	NULL
in	NULL
activation	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
of	NULL
NF	NULL
«	NULL
B	NULL
in	NULL
vitro	NULL
and	NULL
stimulation	NULL
of	NULL
transcription	NULL
from	NULL
the	NULL
NF	NULL
«	NULL
B-dependent	NULL
gene	NULL
expression	NULL
.	NULL

We	NULL
demonstrate	NULL
evidence	NULL
suggesting	NULL
that	NULL
redox	NULL
regulation	NULL
of	NULL
NF	NULL
«	NULL
B	NULL
by	NULL
Trx	NULL
might	NULL
be	NULL
exerted	NULL
at	NULL
a	NULL
step	NULL
after	NULL
dissociation	NULL
of	NULL
the	NULL
inhibitory	NULL
molecule	NULL
I	NULL
«	NULL
B	NULL
,	NULL
a	NULL
cy-tosolic-anchoring	NULL
protein	NULL
for	NULL
NF	NULL
«	NULL
B	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
effect	NULL
of	NULL
Trx	NULL
in	NULL
intact	NULL
cells	NULL
,	NULL
we	NULL
performed	NULL
transient	NULL
assay	NULL
with	NULL
a	NULL
chloramphenicol	NULL
acetyltransferase-ex-pressing	NULL
plasmid	NULL
under	NULL
the	NULL
control	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
long	NULL
terminal	NULL
repeat	NULL
and	NULL
an	NULL
effector	NULL
plasmid	NULL
expressing	NULL
human	NULL
Trx	NULL
.	NULL

The	NULL
promoter	NULL
activity	NULL
from	NULL
HIV	NULL
long	NULL
terminal	NULL
repeat	NULL
was	NULL
greatly	NULL
augmented	NULL
by	NULL
co-transfecting	NULL
the	NULL
Trx-expressing	NULL
plasmid	NULL
,	NULL
whose	NULL
effect	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
NF	NULL
«	NULL
B-binding	NULL
sites	NULL
.	NULL

These	NULL
findings	NULL
have	NULL
suggested	NULL
that	NULL
cysteine	NULL
residue	NULL
(	NULL
s	NULL
)	NULL
of	NULL
NF	NULL
«	NULL
B	NULL
might	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
DNA-recog-nition	NULL
by	NULL
NF	NULL
«	NULL
B	NULL
and	NULL
that	NULL
the	NULL
redox	NULL
control	NULL
mechanism	NULL
mediated	NULL
by	NULL
Trx	NULL
might	NULL
have	NULL
a	NULL
regulatory	NULL
role	NULL
in	NULL
the	NULL
NF	NULL
«	NULL
B-mediated	NULL
gene	NULL
expression	NULL
.	NULL

These	NULL
results	NULL
may	NULL
also	NULL
provide	NULL
a	NULL
clue	NULL
to	NULL
understanding	NULL
of	NULL
the	NULL
molecular	NULL
process	NULL
of	NULL
AIDS	NULL
pathogenesis	NULL
and	NULL
its	NULL
possible	NULL
biochemical	NULL
intervention	NULL
.	NULL

Nuclear	NULL
factor	NULL
k	NULL
B	NULL
(	NULL
NF	NULL
«	NULL
B	NULL
)	NULL
'	NULL
is	NULL
an	NULL
inducible	NULL
cellular	NULL
transcription	NULL
factor	NULL
that	NULL
regulates	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
cellular	NULL
and	NULL
viral	NULL
genes	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Lenardo	NULL
and	NULL
Baltimore	NULL
(	NULL
1989	NULL
)	NULL
and	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Japanese	NULL
Ministry	NULL
of	NULL
Health	NULL
and	NULL
Welfare	NULL
and	NULL
the	NULL
Human	NULL
Science	NULL
Foundation	NULL
(	NULL
Japan	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

T	NULL
Graduate	NULL
student	NULL
under	NULL
the	NULL
tutelage	NULL
of	NULL
Prof.	NULL
Y.	NULL
Ueno	NULL
of	NULL
Faculty	NULL
of	NULL
Pharmaceutical	NULL
Sciences	NULL
,	NULL
Science	NULL
University	NULL
of	NULL
Tokyo	NULL
.	NULL

|	NULL
To	NULL
whom	NULL
all	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
81-3-3542-2511	NULL
;	NULL
Fax	NULL
:	NULL
81-3-3543-2181	NULL
.	NULL

'The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
NFxB	NULL
,	NULL
nuclear	NULL
factor	NULL
«	NULL
k	NULL
B	NULL
;	NULL
Trx	NULL
,	NULL
thioredoxin	NULL
;	NULL
LTR	NULL
,	NULL
long	NULL
terminal	NULL
repeat	NULL
;	NULL
HIV	NULL
,	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
;	NULL
IL-2Ra	NULL
,	NULL
interleukin-2	NULL
receptor	NULL
a	NULL
chain	NULL
;	NULL
IL-2	NULL
,	NULL
interleu-kin-2	NULL
;	NULL
TNF	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
;	NULL
PKC	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
;	NULL
ADF	NULL
,	NULL
adult	NULL
T-cell	NULL
leukemia-derived	NULL
factor	NULL
;	NULL
NAC	NULL
,	NULL
N-acetyl-L-cysteine	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
DOC	NULL
,	NULL
deoxycholate	NULL
;	NULL
BrdU	NULL
,	NULL
bromodeoxyuridine	NULL
;	NULL
2-ME	NULL
,	NULL
2-mercaptoethanol	NULL
;	NULL
PAGE	NULL
,	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
;	NULL
TxR	NULL
,	NULL
thioredoxin	NULL
reductase	NULL
;	NULL
GSH	NULL
,	NULL
glutathione	NULL
;	NULL
DTT	NULL
,	NULL
dithiothreitol	NULL
;	NULL
IxB	NULL
,	NULL
inhibitory	NULL
molecule	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
.	NULL

Greene	NULL
(	NULL
1990	NULL
)	NULL
)	NULL
.	NULL

One	NULL
of	NULL
the	NULL
physiological	NULL
roles	NULL
of	NULL
NF	NULL
«	NULL
B	NULL
is	NULL
to	NULL
control	NULL
gene	NULL
expression	NULL
of	NULL
several	NULL
cellular	NULL
genes	NULL
that	NULL
are	NULL
critical	NULL
for	NULL
immunological	NULL
function	NULL
of	NULL
T-cells	NULL
such	NULL
as	NULL
those	NULL
encoding	NULL
interleukin-2	NULL
receptor	NULL
a	NULL
chain	NULL
(	NULL
IL-Z2Ra	NULL
)	NULL
and	NULL
IL-2	NULL
(	NULL
Bohnlein	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Cross	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Molitor	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Jamieson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
noted	NULL
that	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
also	NULL
contains	NULL
two	NULL
NF	NULL
«	NULL
B-binding	NULL
sites	NULL
(	NULL
called	NULL
``	NULL
kB	NULL
``	NULL
sites	NULL
)	NULL
(	NULL
Dinter	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Nabel	NULL
and	NULL
Baltimore	NULL
,	NULL
1987	NULL
;	NULL
Kawakami	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Okamoto	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
revealed	NULL
that	NULL
the	NULL
xB	NULL
sites	NULL
are	NULL
essential	NULL
in	NULL
transcriptional	NULL
activation	NULL
of	NULL
HIV	NULL
by	NULL
various	NULL
extracellular	NULL
stimuli	NULL
and	NULL
several	NULL
heterologous	NULL
viral	NULL
trans-activators	NULL
(	NULL
Gendelman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Dinter	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Nabel	NULL
and	NULL
Baltimore	NULL
,	NULL
1987	NULL
;	NULL
Bohnlein	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Nabel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Okamoto	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Israel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Ensoli	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Hazan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Schreck	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
has	NULL
been	NULL
suspected	NULL
that	NULL
various	NULL
factors	NULL
that	NULL
activate	NULL
NF	NULL
«	NULL
B	NULL
can	NULL
also	NULL
activate	NULL
HIV	NULL
replication	NULL
and	NULL
thus	NULL
facilitate	NULL
disease	NULL
progression	NULL
of	NULL
acquired	NULL
immunodeficiency	NULL
syndrome	NULL
(	NULL
AIDS	NULL
)	NULL
.	NULL

NF	NULL
«	NULL
B	NULL
appears	NULL
to	NULL
exist	NULL
as	NULL
a	NULL
major	NULL
heterodimer	NULL
composed	NULL
of	NULL
two	NULL
subunits	NULL
with	NULL
molecular	NULL
mass	NULL
values	NULL
of	NULL
50	NULL
and	NULL
65	NULL
kilo-daltons	NULL
(	NULL
called	NULL
p50	NULL
and	NULL
p65	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

cDNAs	NULL
coding	NULL
for	NULL
p50	NULL
and	NULL
p65	NULL
have	NULL
been	NULL
cloned	NULL
(	NULL
Kieran	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Ghosh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Meyer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Ruben	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Sequence	NULL
analysis	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
has	NULL
revealed	NULL
remarkable	NULL
homology	NULL
for	NULL
over	NULL
300	NULL
amino	NULL
acids	NULL
at	NULL
the	NULL
amino-terminal	NULL
end	NULL
of	NULL
both	NULL
proteins	NULL
to	NULL
the	NULL
oncogene	NULL
v-rel	NULL
,	NULL
its	NULL
cellular	NULL
homologue	NULL
c-rel	NULL
,	NULL
and	NULL
the	NULL
Drosophila	NULL
maternal	NULL
effect	NULL
gene	NULL
dorsal	NULL
(	NULL
reviewed	NULL
by	NULL
Gilmore	NULL
(	NULL
1990	NULL
)	NULL
)	NULL
.	NULL

Deletion	NULL
analyses	NULL
of	NULL
p50	NULL
gene	NULL
revealed	NULL
that	NULL
the	NULL
conserved	NULL
NH	NULL
;	NULL
-terminal	NULL
region	NULL
,	NULL
called	NULL
NRD	NULL
(	NULL
for	NULL
NFB	NULL
,	NULL
rel	NULL
,	NULL
dorsal	NULL
)	NULL
domain	NULL
(	NULL
Henkel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
,	NULL
has	NULL
the	NULL
capability	NULL
to	NULL
recognize	NULL
and	NULL
bind	NULL
to	NULL
the	NULL
«	NULL
kB	NULL
sequence	NULL
(	NULL
Kieran	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Ghosh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
although	NULL
no	NULL
known	NULL
DNA-binding	NULL
motif	NULL
has	NULL
been	NULL
identified	NULL
.	NULL

In	NULL
the	NULL
cytosol	NULL
,	NULL
NFB	NULL
is	NULL
in	NULL
an	NULL
inactive	NULL
form	NULL
bound	NULL
to	NULL
an	NULL
inhibitory	NULL
molecule	NULL
,	NULL
IB	NULL
,	NULL
and	NULL
can	NULL
not	NULL
bind	NULL
DNA	NULL
(	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1989	NULL
;	NULL
Urban	NULL
and	NULL
Baeuerle	NULL
,	NULL
1990	NULL
;	NULL
Zabel	NULL
and	NULL
Baeuerle	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
cells	NULL
with	NULL
appropriate	NULL
stimuli	NULL
results	NULL
in	NULL
dissociation	NULL
of	NULL
NFxB	NULL
from	NULL
I	NULL
«	NULL
B	NULL
and	NULL
its	NULL
translocation	NULL
to	NULL
nucleus	NULL
.	NULL

External	NULL
stimuli	NULL
include	NULL
signals	NULL
from	NULL
the	NULL
T-cell	NULL
receptor	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
(	NULL
Okamoto	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Israel	NULL
,	NULL
1989	NULL
;	NULL
Hazan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Meichle	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Jamieson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Schreck	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
NFx	NULL
«	NULL
B	NULL
by	NULL
way	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
dependent	NULL
on	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
(	NULL
Hazan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

However	NULL
,	NULL
TNF-induced	NULL
NFxB	NULL
activation	NULL
has	NULL
been	NULL
found	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
none	NULL
of	NULL
the	NULL
major	NULL
signal-transducing	NULL
kinases	NULL
such	NULL
as	NULL
PKC	NULL
,	NULL
protein	NULL
kinase	NULL
A	NULL
,	NULL
or	NULL
Ca®*-regulated	NULL
kinases	NULL
(	NULL
Meichle	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Feuillard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
(	NULL
see	NULL
Camussi	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
and	NULL
Fiers	NULL
(	NULL
1991	NULL
)	NULL
for	NULL
review	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
Hazan	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
have	NULL
demonstrated	NULL
that	NULL
translocation	NULL
of	NULL
NFxB	NULL
to	NULL
the	NULL
nucleus	NULL
is	NULL
11380	NULL
Redox	NULL
Regulation	NULL
of	NULL
NFxB	NULL
not	NULL
a	NULL
sufficient	NULL
condition	NULL
for	NULL
activating	NULL
the	NULL
«	NULL
B-dependent	NULL
gene	NULL
expression	NULL
from	NULL
the	NULL
HIV	NULL
promoter	NULL
.	NULL

Involvement	NULL
of	NULL
another	NULL
biochemical	NULL
pathway	NULL
has	NULL
thus	NULL
been	NULL
suspected	NULL
.	NULL

Since	NULL
the	NULL
identification	NULL
of	NULL
adult	NULL
T-cell	NULL
leukemia-derived	NULL
factor	NULL
(	NULL
ADF	NULL
)	NULL
,	NULL
initially	NULL
reported	NULL
to	NULL
be	NULL
an	NULL
inducer	NULL
of	NULL
IL-2Ra	NULL
,	NULL
as	NULL
a	NULL
cellular	NULL
reducing	NULL
catalyst	NULL
thioredoxin	NULL
(	NULL
Trx	NULL
)	NULL
(	NULL
Tagaya	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Wakasugi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
it	NULL
has	NULL
been	NULL
implicated	NULL
that	NULL
ADF	NULL
,	NULL
or	NULL
Trx	NULL
,	NULL
might	NULL
activate	NULL
NF	NULL
«	NULL
B	NULL
by	NULL
a	NULL
thiol-redox	NULL
control	NULL
mechanism	NULL
(	NULL
called	NULL
``	NULL
redox	NULL
regulation	NULL
``	NULL
;	NULL
reviewed	NULL
by	NULL
Holmgren	NULL
(	NULL
1985	NULL
,	NULL
1989	NULL
)	NULL
and	NULL
Bauskin	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
)	NULL
.	NULL

An	NULL
intracellular	NULL
signaling	NULL
pathway	NULL
involving	NULL
dithiol-disulfide	NULL
exchange	NULL
reactions	NULL
of	NULL
cysteine	NULL
residues	NULL
on	NULL
protein	NULL
molecule	NULL
by	NULL
redox	NULL
regulation	NULL
has	NULL
been	NULL
implicated	NULL
to	NULL
play	NULL
a	NULL
part	NULL
in	NULL
transducing	NULL
the	NULL
TNF	NULL
signal	NULL
(	NULL
Schreck	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Molitor	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
(	NULL
reviewed	NULL
by	NULL
Camussi	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
and	NULL
Fiers	NULL
(	NULL
1991	NULL
)	NULL
)	NULL
.	NULL

We	NULL
and	NULL
others	NULL
have	NULL
recently	NULL
reported	NULL
that	NULL
the	NULL
oxidoreductive	NULL
condition	NULL
of	NULL
NFB	NULL
regulates	NULL
its	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
Toledano	NULL
and	NULL
Leonard	NULL
,	NULL
1991	NULL
;	NULL
Molitor	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Tsuboi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Okamoto	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Matthews	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
and	NULL
presented	NULL
initial	NULL
observations	NULL
that	NULL
a	NULL
cellular	NULL
reducing	NULL
catalyst	NULL
Trx	NULL
might	NULL
be	NULL
involved	NULL
(	NULL
Okamoto	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Matthews	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
attempted	NULL
to	NULL
clarify	NULL
the	NULL
biochemical	NULL
actions	NULL
of	NULL
Trx	NULL
in	NULL
the	NULL
signaling	NULL
pathway	NULL
that	NULL
regulates	NULL
the	NULL
NFx	NULL
«	NULL
B	NULL
activity	NULL
and	NULL
the	NULL
NF	NULL
«	NULL
B-mediated	NULL
gene	NULL
expression	NULL
using	NULL
HIV	NULL
as	NULL
a	NULL
model	NULL
system	NULL
.	NULL

We	NULL
demonstrate	NULL
evidence	NULL
suggesting	NULL
that	NULL
redox	NULL
control	NULL
mechanism	NULL
may	NULL
well	NULL
be	NULL
serving	NULL
as	NULL
an	NULL
alternative	NULL
or	NULL
anciliary	NULL
pathway	NULL
for	NULL
controlling	NULL
the	NULL
NFB	NULL
activity	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
known	NULL
pathways	NULL
involving	NULL
phos-phorylation	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
Culture	NULL
,	NULL
Preparation	NULL
of	NULL
Nuclear	NULL
and	NULL
Cytosolic	NULL
Extracts	NULL
,	NULL
and	NULL
Protein	NULL
Purification-Peripheral	NULL
blood	NULL
mononuclear	NULL
leukocytes	NULL
were	NULL
isolated	NULL
from	NULL
heparinized	NULL
venous	NULL
blood	NULL
obtained	NULL
from	NULL
healthy	NULL
individuals	NULL
after	NULL
centrifugal	NULL
separation	NULL
on	NULL
Histopaque	NULL
(	NULL
Sigma	NULL
)	NULL
gradients	NULL
.	NULL

Collected	NULL
mononuclear	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
RPMI	NULL
1640	NULL
medium	NULL
and	NULL
cultured	NULL
for	NULL
3	NULL
days	NULL
in	NULL
AIM-V	NULL
medium	NULL
(	NULL
GIBCO	NULL
)	NULL
with	NULL
stimulation	NULL
by	NULL
plate-coated	NULL
anti-CD3	NULL
murine	NULL
monoclonal	NULL
antibody	NULL
(	NULL
OKT	NULL
3	NULL
,	NULL
Jans-sen-Kyowa	NULL
,	NULL
Co.	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
transferred	NULL
to	NULL
a	NULL
gas-permeable	NULL
culture	NULL
bag	NULL
(	NULL
SteriCeil	NULL
,	NULL
Du	NULL
Pont	NULL
)	NULL
and	NULL
cultivation	NULL
was	NULL
continued	NULL
with	NULL
AIM-V	NULL
supplemented	NULL
with	NULL
insulin	NULL
(	NULL
0.2	NULL
units/ml	NULL
)	NULL
,	NULL
heat-treated	NULL
human	NULL
serum	NULL
(	NULL
1	NULL
%	NULL
;	NULL
type-compatible	NULL
)	NULL
,	NULL
and	NULL
recombinant	NULL
IL-2	NULL
(	NULL
700	NULL
Jurkat	NULL
units/ml	NULL
,	NULL
Shionogi	NULL
Pharmaceutical	NULL
Co.	NULL
,	NULL
Osaka	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

Cytofluorometric	NULL
analyses	NULL
were	NULL
carried	NULL
out	NULL
sequentially	NULL
to	NULL
determine	NULL
the	NULL
lymphocyte	NULL
subpopulations	NULL
in	NULL
culture	NULL
(	NULL
representative	NULL
data	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

After	NULL
10	NULL
days	NULL
of	NULL
culture	NULL
,	NULL
the	NULL
total	NULL
cell	NULL
number	NULL
reached	NULL
0.5-2.0	NULL
x	NULL
10	NULL
``	NULL
and	NULL
cells	NULL
were	NULL
still	NULL
in	NULL
the	NULL
growing	NULL
phase	NULL
.	NULL

Flow	NULL
cytometric	NULL
examination	NULL
of	NULL
the	NULL
cultured	NULL
primary	NULL
lymphocytes	NULL
revealed	NULL
82.2	NULL
%	NULL
CD3-positive	NULL
,	NULL
39.6	NULL
%	NULL
CD4-positive	NULL
,	NULL
42.8	NULL
%	NULL
CD8-positive	NULL
,	NULL
22.7	NULL
%	NULL
CD25	NULL
(	NULL
IL-ZRa	NULL
)	NULL
-positive	NULL
,	NULL
and	NULL
only	NULL
0.8	NULL
%	NULL
CD16-posi-tive	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
and	NULL
nuclear	NULL
and	NULL
cytosolic	NULL
extracts	NULL
were	NULL
prepared	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
.	NULL

The	NULL
crude	NULL
nuclear	NULL
extract	NULL
was	NULL
fractionated	NULL
on	NULL
heparin-Sepharose	NULL
and	NULL
DEAE-Sepharose	NULL
columns	NULL
(	NULL
Wu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Okamoto	NULL
and	NULL
Wong-Staal	NULL
,	NULL
1986	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

The	NULL
soluble	NULL
cytosolic	NULL
extract	NULL
,	NULL
S100	NULL
,	NULL
was	NULL
fractionated	NULL
to	NULL
obtain	NULL
NFxB/I	NULL
«	NULL
B	NULL
complex	NULL
(	NULL
Ghosh	NULL
and	NULL
Baltimore	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

The	NULL
schematic	NULL
diagram	NULL
of	NULL
protein	NULL
fractionation	NULL
of	NULL
the	NULL
nuclear	NULL
and	NULL
cytosolic	NULL
(	NULL
$	NULL
100	NULL
)	NULL
extracts	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
.	NULL

Briefly	NULL
,	NULL
approximately	NULL
5	NULL
ml	NULL
(	NULL
8-12	NULL
mg	NULL
of	NULL
protein/ml	NULL
)	NULL
of	NULL
crude	NULL
nuclear	NULL
extract	NULL
in	NULL
the	NULL
D	NULL
buffer	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
was	NULL
applied	NULL
to	NULL
a	NULL
20-ml	NULL
heparin-Sepharose	NULL
column	NULL
and	NULL
eluted	NULL
by	NULL
buffer	NULL
D	NULL
containing	NULL
0.4	NULL
M	NULL
KCI	NULL
.	NULL

After	NULL
dialysis	NULL
,	NULL
this	NULL
eluate	NULL
fraction	NULL
was	NULL
applied	NULL
to	NULL
a	NULL
10-ml	NULL
DEAE-Sepharose	NULL
column	NULL
.	NULL

The	NULL
flow-through	NULL
,	NULL
0.1	NULL
M	NULL
,	NULL
0.15	NULL
M	NULL
,	NULL
0.2	NULL
M	NULL
,	NULL
and	NULL
0.3	NULL
M	NULL
KCl	NULL
eluate	NULL
fractions	NULL
were	NULL
concentrated	NULL
to	NULL
the	NULL
initial	NULL
cell	NULL
pack	NULL
volume	NULL
,	NULL
dialyzed	NULL
against	NULL
the	NULL
starting	NULL
buffer	NULL
without	NULL
DTT	NULL
,	NULL
and	NULL
stored	NULL
in	NULL
liquid	NULL
nitrogen	NULL
.	NULL

The	NULL
$	NULL
100	NULL
cytosolic	NULL
fraction	NULL
was	NULL
first	NULL
passed	NULL
through	NULL
a	NULL
DEAE-Sepharose	NULL
column	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
0.28	NULL
M	NULL
KCl	NULL
to	NULL
remove	NULL
nucleic	NULL
acids	NULL
.	NULL

The	NULL
flow-through	NULL
fraction	NULL
was	NULL
dialyzed	NULL
and	NULL
loaded	NULL
onto	NULL
another	NULL
DEAE-Sepharose	NULL
column	NULL
,	NULL
and	NULL
protein	NULL
was	NULL
eluted	NULL
by	NULL
a	NULL
continuous	NULL
KCl	NULL
gradient	NULL
.	NULL

The	NULL
cytosolic	NULL
NFxB/IxB	NULL
complex	NULL
was	NULL
detected	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
detergent	NULL
11381	NULL
mixture	NULL
containing	NULL
1.2	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
and	NULL
0.8	NULL
%	NULL
deoxycholate	NULL
(	NULL
DOC	NULL
)	NULL
.	NULL

The	NULL
DEAE	NULL
fractions	NULL
containing	NULL
this	NULL
complex	NULL
were	NULL
further	NULL
fractionated	NULL
through	NULL
phosphocellulose	NULL
,	NULL
heparin-Sepharose	NULL
,	NULL
and	NULL
DEAE-Sepharose	NULL
columns	NULL
.	NULL

The	NULL
0.2	NULL
M	NULL
KC	NULL
]	NULL
eluate	NULL
from	NULL
the	NULL
last	NULL
DEAE	NULL
column	NULL
was	NULL
concentrated	NULL
by	NULL
ultrafiltration	NULL
(	NULL
Centriprep	NULL
,	NULL
Amicon	NULL
Corp.	NULL
)	NULL
and	NULL
was	NULL
further	NULL
fractionated	NULL
by	NULL
a	NULL
glycerol	NULL
gradient	NULL
centrifugation	NULL
(	NULL
no	NULL
DTT	NULL
was	NULL
added	NULL
in	NULL
the	NULL
buffer	NULL
)	NULL
.	NULL

For	NULL
the	NULL
experiments	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
preparation	NULL
and	NULL
fractionation	NULL
of	NULL
the	NULL
cytosolic	NULL
NFxB	NULL
was	NULL
carried	NULL
out	NULL
using	NULL
deaerated	NULL
and	NULL
N	NULL
;	NULL
-saturated	NULL
buffers	NULL
and	NULL
no	NULL
artificial	NULL
reductant	NULL
was	NULL
added	NULL
.	NULL

NFxB	NULL
activities	NULL
were	NULL
recovered	NULL
in	NULL
the	NULL
0.2	NULL
M	NULL
KCl	NULL
eluate	NULL
from	NULL
the	NULL
DEAE-Sepharose	NULL
column	NULL
chromatography	NULL
of	NULL
the	NULL
nuclear	NULL
extract	NULL
(	NULL
DEO.2	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
and	NULL
in	NULL
two	NULL
fractions	NULL
obtained	NULL
from	NULL
the	NULL
glycerol	NULL
gradient	NULL
centrifugation	NULL
of	NULL
the	NULL
column-fractionated	NULL
cytosolic	NULL
extract	NULL
(	NULL
fractions	NULL
2	NULL
and	NULL
3	NULL
)	NULL
(	NULL
Figs	NULL
.	NULL

2C	NULL
and	NULL
54	NULL
)	NULL
.	NULL

These	NULL
NFB	NULL
preparations	NULL
did	NULL
not	NULL
contain	NULL
any	NULL
detectable	NULL
level	NULL
of	NULL
T'rx	NULL
as	NULL
revealed	NULL
by	NULL
immunoblotting	NULL
using	NULL
the	NULL
specific	NULL
antiserum	NULL
.	NULL

Oligonucleotides-Oligodeoxynucleotides	NULL
for	NULL
the	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
used	NULL
for	NULL
DNA-binding	NULL
assays	NULL
as	NULL
probes	NULL
or	NULL
competitors	NULL
were	NULL
synthesized	NULL
on	NULL
a	NULL
DNA	NULL
synthesizer	NULL
(	NULL
type	NULL
380A	NULL
,	NULL
Applied	NULL
Biosystems	NULL
)	NULL
by	NULL
the	NULL
phosphoramidite	NULL
method	NULL
and	NULL
purified	NULL
on	NULL
OPC	NULL
cartridge	NULL
(	NULL
Applied	NULL
Biosystems	NULL
)	NULL
according	NULL
to	NULL
the	NULL
instructions	NULL
provided	NULL
by	NULL
the	NULL
manufac-turer	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
double-stranded	NULL
oligonucleotide	NULL
encompass	NULL
the	NULL
«	NULL
B	NULL
motif	NULL
from	NULL
the	NULL
HIV-1	NULL
or	NULL
IL-2R	NULL
«	NULL
enhancers	NULL
.	NULL

DNA	NULL
sequences	NULL
of	NULL
these	NULL
synthetic	NULL
oligonucleotides	NULL
for	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
and	NULL
of	NULL
the	NULL
mutant	NULL
were	NULL
as	NULL
follows	NULL
.	NULL

HIV	NULL
«	NULL
B	NULL
wild	NULL
type	NULL
:	NULL
HIV	NULL
«	NULL
B	NULL
mutant	NULL
:	NULL
IL-2Ra	NULL
«	NULL
B	NULL
:	NULL
Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
(	NULL
EMSA	NULL
)	NULL
-The	NULL
double-stranded	NULL
xB	NULL
oligonucleotide	NULL
,	NULL
HIV	NULL
«	NULL
B	NULL
wild	NULL
type	NULL
,	NULL
was	NULL
end-labeled	NULL
using	NULL
[	NULL
aP	NULL
]	NULL
dATP	NULL
and	NULL
Klenow	NULL
polymerase	NULL
.	NULL

Binding	NULL
reactions	NULL
of	NULL
the	NULL
DNA	NULL
probe	NULL
with	NULL
protein	NULL
were	NULL
performed	NULL
at	NULL
30°C	NULL
for	NULL
10	NULL
min	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
10	NULL
gl	NULL
of	NULL
buffer	NULL
containing	NULL
22	NULL
mM	NULL
HEPES-KOH	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
60	NULL
mm	NULL
KCI	NULL
,	NULL
1	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
0.02	NULL
mM	NULL
EDTA	NULL
,	NULL
5	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
glycerol	NULL
,	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
1.0	NULL
4g	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
and	NULL
0.1	NULL
ng	NULL
(	NULL
20,000-30,000	NULL
cpm	NULL
)	NULL
of	NULL
the	NULL
labeled	NULL
probe	NULL
.	NULL

The	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
resolved	NULL
on	NULL
nondenaturing	NULL
6	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

Electrophoresis	NULL
was	NULL
performed	NULL
with	NULL
0.5	NULL
x	NULL
TBE	NULL
buffer	NULL
(	NULL
4.5	NULL
mM	NULL
Tris	NULL
,	NULL
4.5	NULL
mM	NULL
boric	NULL
acid	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
pH8.0	NULL
)	NULL
at	NULL
4°C	NULL
.	NULL

Upon	NULL
EMSA	NULL
,	NULL
NF	NULL
«	NULL
B	NULL
usually	NULL
gave	NULL
two	NULL
retarded	NULL
bands	NULL
,	NULL
as	NULL
reported	NULL
previously	NULL
(	NULL
Bohnlein	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Meyer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Okamoto	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
lower	NULL
band	NULL
was	NULL
first	NULL
seen	NULL
with	NULL
a	NULL
smaller	NULL
amount	NULL
of	NULL
the	NULL
NFxB	NULL
fractions	NULL
(	NULL
DEO.2	NULL
or	NULL
fraction	NULL
3	NULL
)	NULL
,	NULL
the	NULL
upper	NULL
and	NULL
lower	NULL
bands	NULL
might	NULL
represent	NULL
tetramer	NULL
and	NULL
dimer	NULL
complexes	NULL
,	NULL
respectively	NULL
(	NULL
see	NULL
,	NULL
for	NULL
example	NULL
,	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
(	NULL
1989	NULL
)	NULL
)	NULL
.	NULL

The	NULL
intensity	NULL
of	NULL
the	NULL
upper	NULL
band	NULL
relative	NULL
to	NULL
the	NULL
lower	NULL
band	NULL
varied	NULL
among	NULL
the	NULL
different	NULL
preparations	NULL
and	NULL
might	NULL
reflect	NULL
variations	NULL
during	NULL
the	NULL
protein	NULL
extraction	NULL
procedures	NULL
.	NULL

For	NULL
the	NULL
competition	NULL
experiments	NULL
,	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
HIV	NULL
«	NULL
B	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
,	NULL
HIV	NULL
xB	NULL
mutant	NULL
(	NULL
mut	NULL
)	NULL
,	NULL
or	NULL
IL-2Ra	NULL
oligonucleotides	NULL
were	NULL
preincubated	NULL
with	NULL
the	NULL
protein	NULL
on	NULL
ice	NULL
for	NULL
5	NULL
min	NULL
before	NULL
adding	NULL
the	NULL
radioactive	NULL
probe	NULL
.	NULL

UV	NULL
Cross-linking-All	NULL
the	NULL
procedures	NULL
were	NULL
essentially	NULL
as	NULL
described	NULL
by	NULL
Cereghini	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
.	NULL

The	NULL
bromodeoxyuridine	NULL
(	NULL
BrdU	NULL
)	NULL
-substi-tuted	NULL
HIV	NULL
«	NULL
B	NULL
oligonucleotides	NULL
,	NULL
where	NULL
the	NULL
thymidine	NULL
residues	NULL
were	NULL
substituted	NULL
by	NULL
BrdU	NULL
,	NULL
were	NULL
custom-synthesized	NULL
by	NULL
Takara	NULL
Shuzo	NULL
Co.	NULL
,	NULL
Ltd.	NULL
(	NULL
Kyoto	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

BrdU	NULL
substitution	NULL
did	NULL
not	NULL
change	NULL
the	NULL
specificity	NULL
or	NULL
the	NULL
affinity	NULL
for	NULL
NF	NULL
«	NULL
B	NULL
binding	NULL
as	NULL
measured	NULL
by	NULL
EMSA	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
BrdU-substituted	NULL
«	NULL
B	NULL
probe	NULL
was	NULL
end-labeled	NULL
with	NULL
[	NULL
a-	NULL
``	NULL
P	NULL
]	NULL
dATP	NULL
by	NULL
Klenow	NULL
polymerase	NULL
and	NULL
incubated	NULL
with	NULL
2	NULL
ul	NULL
each	NULL
of	NULL
the	NULL
DEAE-Sepharose	NULL
fractions	NULL
of	NULL
the	NULL
nuclear	NULL
extract	NULL
,	NULL
flow-through	NULL
,	NULL
DEO.1	NULL
,	NULL
DEO.15	NULL
,	NULL
DEO.2	NULL
,	NULL
or	NULL
DEO.3	NULL
in	NULL
EMSA	NULL
buffer	NULL
at	NULL
30	NULL
°C	NULL
for	NULL
25	NULL
min	NULL
.	NULL

For	NULL
competition	NULL
assays	NULL
,	NULL
DEO.2	NULL
(	NULL
containing	NULL
NF	NULL
«	NULL
B	NULL
)	NULL
was	NULL
premixed	NULL
on	NULL
ice	NULL
for	NULL
5	NULL
min	NULL
with	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
HIV	NULL
«	NULL
B	NULL
(	NULL
wt	NULL
)	NULL
,	NULL
HIV	NULL
«	NULL
B	NULL
(	NULL
mut	NULL
)	NULL
,	NULL
or	NULL
IL-2Ra	NULL
oligonucleotides	NULL
before	NULL
addition	NULL
of	NULL
the	NULL
labeled	NULL
probe	NULL
.	NULL

After	NULL
DNA-protein	NULL
binding	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
placed	NULL
5	NULL
cm	NULL
distant	NULL
from	NULL
a	NULL
UV	NULL
lamp	NULL
(	NULL
253.7	NULL
nm	NULL
,	NULL
using	NULL
a	NULL
sterilization	NULL
lamp	NULL
,	NULL
GL15	NULL
,	NULL
Toshiba	NULL
,	NULL
Japan	NULL
)	NULL
and	NULL
irradiated	NULL
on	NULL
ice	NULL
for	NULL
45	NULL
min	NULL
.	NULL

After	NULL
addition	NULL
of	NULL
10	NULL
ul	NULL
of	NULL
sampling	NULL
buffer	NULL
(	NULL
2.5	NULL
%	NULL
SDS	NULL
,	NULL
0.65	NULL
mm	NULL
DTT	NULL
,	NULL
0.5	NULL
m	NULL
sucrose	NULL
)	NULL
for	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
PAGE	NULL
)	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
boiled	NULL
for	NULL
5	NULL
min	NULL
,	NULL
separated	NULL
on	NULL
a	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
gel	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
autoradiography	NULL
.	NULL

Oxidoreductive	NULL
Reagents	NULL
and	NULL
Reactions-Recombinant	NULL
human	NULL
thioredoxin	NULL
(	NULL
Trx	NULL
)	NULL
,	NULL
also	NULL
known	NULL
as	NULL
adult	NULL
T-cell	NULL
leukemia-derived	NULL
factor	NULL
(	NULL
ADF	NULL
)	NULL
(	NULL
Tagaya	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
,	NULL
its	NULL
mutant	NULL
with	NULL
a	NULL
single	NULL
amino	NULL
acid	NULL
replacement	NULL
of	NULL
cysteine	NULL
31	NULL
by	NULL
serine	NULL
(	NULL
Mitsui	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
,	NULL
and	NULL
thioredoxin	NULL
reductase	NULL
(	NULL
TxR	NULL
)	NULL
purified	NULL
from	NULL
rat	NULL
liver	NULL
were	NULL
generous	NULL
gifts	NULL
from	NULL
Dr.	NULL
Mitsui	NULL
,	NULL
Basic	NULL
Research	NULL
Laboratories	NULL
,	NULL
Ajinomoto	NULL
Co.	NULL
,	NULL
Inc.	NULL
,	NULL
Kawasaki	NULL
,	NULL
Japan	NULL
.	NULL

Trx	NULL
and	NULL
its	NULL
mutant	NULL
were	NULL
purified	NULL
to	NULL
homogeneity	NULL
,	NULL
GATCTAGGGACTTTCCGCTGGGGACTTTCCAG	NULL
GATCTActCACTTTCCGCTGetcACTTTCCAG	NULL
GATCTCAGGGGAATCTCCCTCTCCTTTTATGGGCGTAGCG	NULL
11382	NULL
incubated	NULL
with	NULL
1	NULL
mM	NULL
DTT	NULL
for	NULL
16	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
,	NULL
dialyzed	NULL
against	NULL
a	NULL
buffer	NULL
containing	NULL
20	NULL
mM	NULL
HEPES-KOH	NULL
(	NULL
pH7.9	NULL
)	NULL
,	NULL
60	NULL
mm	NULL
KCl	NULL
,	NULL
0.1	NULL
mm	NULL
EDTA	NULL
,	NULL
and	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
stored	NULL
in	NULL
liquid	NULL
nitrogen	NULL
(	NULL
``	NULL
fully	NULL
reduced	NULL
form	NULL
``	NULL
)	NULL
.	NULL

Some	NULL
were	NULL
stored	NULL
at	NULL
-20	NULL
°C	NULL
to	NULL
be	NULL
naturally	NULL
oxidized	NULL
.	NULL

Measurement	NULL
of	NULL
free	NULL
sulfhydryl	NULL
(	NULL
SH	NULL
)	NULL
contents	NULL
using	NULL
5,5	NULL
``	NULL
-dithiobis	NULL
revealed	NULL
that	NULL
average	NULL
free	NULL
SH	NULL
contents	NULL
of	NULL
the	NULL
fully	NULL
reduced	NULL
and	NULL
the	NULL
``	NULL
naturally	NULL
oxidized	NULL
``	NULL
Trx	NULL
were	NULL
84	NULL
and	NULL
32	NULL
%	NULL
,	NULL
respectively	NULL
.	NULL

Chemical	NULL
oxidation	NULL
of	NULL
the	NULL
thiols	NULL
on	NULL
NFkB	NULL
was	NULL
performed	NULL
by	NULL
treating	NULL
the	NULL
nuclear	NULL
and	NULL
the	NULL
cytosolic	NULL
fractions	NULL
containing	NULL
NF	NULL
«	NULL
B	NULL
by	NULL
diamide	NULL
,	NULL
an	NULL
inorganic	NULL
catalyst	NULL
of	NULL
oxidation	NULL
of	NULL
dithiols	NULL
(	NULL
(	NULL
SH	NULL
)	NULL
;	NULL
)	NULL
to	NULL
generate	NULL
disulfides	NULL
(	NULL
-S-S-	NULL
)	NULL
,	NULL
on	NULL
ice	NULL
for	NULL
5	NULL
min	NULL
in	NULL
the	NULL
EMSA	NULL
buffer	NULL
.	NULL

Reversion	NULL
of	NULL
the	NULL
disulfides	NULL
to	NULL
dithiols	NULL
was	NULL
carried	NULL
out	NULL
by	NULL
treating	NULL
with	NULL
various	NULL
reducing	NULL
reagents	NULL
.	NULL

Reactions	NULL
with	NULL
Trx	NULL
system	NULL
,	NULL
containing	NULL
various	NULL
concentrations	NULL
of	NULL
human	NULL
Trx	NULL
(	NULL
naturally	NULL
oxidized	NULL
form	NULL
)	NULL
,	NULL
TxR	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
NADPH	NULL
were	NULL
performed	NULL
at	NULL
25	NULL
°C	NULL
for	NULL
5	NULL
min	NULL
.	NULL

This	NULL
reaction	NULL
condition	NULL
was	NULL
sufficient	NULL
to	NULL
fully	NULL
reduce	NULL
the	NULL
naturally	NULL
oxidized	NULL
Trx	NULL
as	NULL
examined	NULL
by	NULL
insulin	NULL
reduction	NULL
assay	NULL
(	NULL
Luthman	NULL
and	NULL
Holmgren	NULL
,	NULL
1982	NULL
)	NULL
.	NULL

Other	NULL
reducing	NULL
agents	NULL
,	NULL
DTT	NULL
,	NULL
2-ME	NULL
,	NULL
glutathione	NULL
(	NULL
GSH	NULL
)	NULL
,	NULL
and	NULL
glutathione	NULL
reductase	NULL
,	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
.	NULL

Chloramphenicol	NULL
Acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
Assay-Jurkat	NULL
or	NULL
COS-1	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
reporter	NULL
plasmid	NULL
,	NULL
HIV	NULL
«	NULL
B	NULL
(	NULL
wt	NULL
)	NULL
or	NULL
HIV	NULL
«	NULL
B	NULL
(	NULL
mut	NULL
)	NULL
.	NULL

In	NULL
HIV	NULL
«	NULL
B	NULL
(	NULL
mut	NULL
)	NULL
,	NULL
the	NULL
«	NULL
B	NULL
sequence	NULL
GGGACTTTCC	NULL
was	NULL
substituted	NULL
by	NULL
CTCACTTTCC	NULL
(	NULL
as	NULL
described	NULL
by	NULL
Nabel	NULL
and	NULL
Baltimore	NULL
(	NULL
1987	NULL
)	NULL
)	NULL
.	NULL

Ten	NULL
micrograms	NULL
of	NULL
the	NULL
reporter	NULL
plasmid	NULL
was	NULL
transfected	NULL
to	NULL
Jurkat	NULL
or	NULL
COS-1	NULL
cells	NULL
in	NULL
combination	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
the	NULL
Trx-expressing	NULL
plasmid	NULL
,	NULL
SReADF	NULL
(	NULL
Tagaya	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
(	NULL
which	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
Dr.	NULL
J.	NULL
Yodoi	NULL
,	NULL
Virus	NULL
Research	NULL
Institute	NULL
,	NULL
Kyoto	NULL
University	NULL
,	NULL
Kyoto	NULL
,	NULL
Japan	NULL
)	NULL
or	NULL
the	NULL
vector	NULL
control	NULL
,	NULL
SRa	NULL
«	NULL
,	NULL
by	NULL
the	NULL
methods	NULL
previously	NULL
described	NULL
(	NULL
Chen	NULL
and	NULL
Okayama	NULL
,	NULL
1987	NULL
;	NULL
Mori	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

One	NULL
microgram	NULL
of	NULL
RSV	NULL
-gal	NULL
plasmid	NULL
was	NULL
also	NULL
co-transfected	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
24-60	NULL
h	NULL
after	NULL
the	NULL
medium	NULL
change	NULL
following	NULL
the	NULL
transfection	NULL
,	NULL
and	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
sonication	NULL
and	NULL
heat	NULL
treatment	NULL
at	NULL
60	NULL
°C	NULL
for	NULL
10	NULL
min	NULL
.	NULL

Protein	NULL
concentrations	NULL
were	NULL
determined	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Bradford	NULL
(	NULL
using	NULL
a	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
)	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
determined	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Okamoto	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Mori	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

CAT	NULL
enzyme	NULL
reactions	NULL
were	NULL
performed	NULL
with	NULL
70	NULL
ug	NULL
of	NULL
protein	NULL
in	NULL
a	NULL
reaction	NULL
mixture	NULL
of	NULL
100	NULL
l.	NULL
Incubation	NULL
was	NULL
carried	NULL
out	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
8	NULL
h.	NULL
Reaction	NULL
products	NULL
were	NULL
analyzed	NULL
by	NULL
thin-layer	NULL
chromatography	NULL
followed	NULL
by	NULL
autoradiography	NULL
.	NULL

Quantitation	NULL
of	NULL
the	NULL
CAT	NULL
enzyme	NULL
activity	NULL
(	NULL
%	NULL
conversion	NULL
)	NULL
was	NULL
calculated	NULL
based	NULL
on	NULL
the	NULL
measurement	NULL
of	NULL
radioactive	NULL
signals	NULL
using	NULL
an	NULL
image	NULL
analyzer	NULL
(	NULL
Fuji	NULL
Film	NULL
Co.	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

To	NULL
adjust	NULL
the	NULL
transfection	NULL
efficiency	NULL
,	NULL
quantitation	NULL
of	NULL
the	NULL
A-galactosidase	NULL
gene	NULL
product	NULL
was	NULL
carried	NULL
out	NULL
by	NULL
im-munoblot	NULL
analysis	NULL
using	NULL
the	NULL
specific	NULL
antiserum	NULL
.	NULL

RESULTS	NULL
Preparation	NULL
and	NULL
Identification	NULL
of	NULL
the	NULL
Nuclear	NULL
and	NULL
the	NULL
Cytosolic	NULL
NFxB-We	NULL
prepared	NULL
nuclear	NULL
and	NULL
cytosolic	NULL
extracts	NULL
from	NULL
primary	NULL
human	NULL
lymphocytes	NULL
after	NULL
short	NULL
term	NULL
culture	NULL
.	NULL

After	NULL
10	NULL
days	NULL
in	NULL
culture	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
still	NULL
growing	NULL
while	NULL
CD25-	NULL
(	NULL
or	NULL
IL-2Ra	NULL
)	NULL
-positive	NULL
cells	NULL
were	NULL
about	NULL
20	NULL
%	NULL
and	NULL
rapidly	NULL
decreasing	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
expected	NULL
NFB	NULL
in	NULL
both	NULL
the	NULL
nucleus	NULL
and	NULL
the	NULL
cytoplasm	NULL
at	NULL
this	NULL
stage	NULL
and	NULL
harvested	NULL
cells	NULL
for	NULL
preparation	NULL
of	NULL
nuclear	NULL
and	NULL
cytosolic	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
detected	NULL
by	NULL
EMSA	NULL
in	NULL
the	NULL
nuclear	NULL
fractions	NULL
eluted	NULL
from	NULL
DEAE-Sepharose	NULL
with	NULL
0.1	NULL
M	NULL
(	NULL
DEO.1	NULL
)	NULL
and	NULL
0.2	NULL
M	NULL
KCl	NULL
(	NULL
DEO.2	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Cold	NULL
competition	NULL
experiments	NULL
with	NULL
oligonucleotide	NULL
DNAs	NULL
containing	NULL
the	NULL
wild-type	NULL
or	NULL
the	NULL
mutant	NULL
«	NULL
B	NULL
sequences	NULL
were	NULL
performed	NULL
to	NULL
determine	NULL
the	NULL
sequence	NULL
specificity	NULL
of	NULL
these	NULL
DNA-binding	NULL
proteins	NULL
.	NULL

The	NULL
«	NULL
B-binding	NULL
activity	NULL
in	NULL
the	NULL
DEO.2	NULL
fraction	NULL
was	NULL
specifically	NULL
competed	NULL
by	NULL
preincubation	NULL
with	NULL
the	NULL
unlabeled	NULL
«	NULL
B	NULL
oligonucleotides	NULL
but	NULL
not	NULL
with	NULL
the	NULL
mutant	NULL
«	NULL
B	NULL
oligonucleotide	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
similar	NULL
experiments	NULL
with	NULL
DEO.1	NULL
revealed	NULL
no	NULL
sequence	NULL
specificity	NULL
to	NULL
the	NULL
«	NULL
B	NULL
sequence	NULL
.	NULL

Incubation	NULL
of	NULL
DEO.2	NULL
with	NULL
a	NULL
monoclonal	NULL
antibody	NULL
to	NULL
NF	NULL
«	NULL
B	NULL
(	NULL
Rel	NULL
homology	NULL
region	NULL
)	NULL
(	NULL
c-rel/NFxB	NULL
cross-reactive	NULL
mouse	NULL
monoclonal	NULL
antibody	NULL
,	NULL
American	NULL
Bio-Technologies	NULL
Inc.	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
abolished	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
EMSA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
carried	NULL
out	NULL
UV	NULL
cross-linking	NULL
experiment	NULL
to	NULL
identify	NULL
the	NULL
«	NULL
B-binding	NULL
protein	NULL
.	NULL

After	NULL
incubation	NULL
with	NULL
the	NULL
probe	NULL
,	NULL
the	NULL
DNA-protein	NULL
complex	NULL
was	NULL
cross-linked	NULL
by	NULL
UV	NULL
irradiation	NULL
and	NULL
resolved	NULL
on	NULL
SDS-PAGE	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
a	NULL
single	NULL
Redox	NULL
Regulation	NULL
of	NULL
NFxB	NULL
Stimulation	NULL
with	NULL
Anti-CD3	NULL
Ab	NULL
|	NULL
€	NULL
--	NULL
--	NULL
-	NULL
>	NULL
Days	NULL
in	NULL
Culture	NULL
Human	NULL
Primary	NULL
T	NULL
Lymphocytes	NULL
Grown	NULL
in	NULL
Culture	NULL
with	NULL
Anti-CD3	NULL
Ab	NULL
Preparation	NULL
of	NULL
Nuclear	NULL
(	NULL
N	NULL
)	NULL
and	NULL
Cytosol	NULL
(	NULL
Cy	NULL
)	NULL
Fractions	NULL
N	NULL
Cy	NULL
(	NULL
$	NULL
100	NULL
)	NULL
Heparin	NULL
Sepharose	NULL
DEAE	NULL
Sepharose	NULL
(	NULL
0.28	NULL
M	NULL
KC	NULL
)	NULL
)	NULL
0.1	NULL
0,4	NULL
-	NULL
1.0	NULL
MKC	NULL
]	NULL
DEAE	NULL
Sepharose	NULL
_	NULL
s	NULL
o.3s	NULL
DEAF	NULL
pepharos®	NULL
(	NULL
0.12-0.15	NULL
M	NULL
Ken	NULL
T	NULL
n	NULL
,	NULL
hosphocellulose	NULL
(	NULL
0.1	NULL
M	NULL
pos	NULL
o.1	NULL
o1s	NULL
o2	NULL
3	NULL
_	NULL
Phosphogelluiese	NULL
{	NULL
0.1	NULL
MKC	NULL
)	NULL
Heparin	NULL
slopharou	NULL
(	NULL
0.1	NULL
M	NULL
KC	NULL
)	NULL
DEAE	NULL
Ephnrou	NULL
al	NULL
l2	NULL
Concentration	NULL
by	NULL
uttratiitration	NULL
NFeS	NULL
Glycerol	NULL
gradient	NULL
centrifugation	NULL
10	NULL
_-	NULL
,	NULL
30	NULL
%	NULL
|	NULL
(	NULL
24-23	NULL
%	NULL
)	NULL
NFeB.Ir3	NULL
somplex	NULL
FiG	NULL
.	NULL

1	NULL
.	NULL

Lymphocyte	NULL
culture	NULL
and	NULL
preparation	NULL
of	NULL
the	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
NF	NULL
«	NULL
B	NULL
.	NULL

A	NULL
,	NULL
cytofluorometric	NULL
analyses	NULL
of	NULL
the	NULL
primary	NULL
lymphocytes	NULL
in	NULL
culture	NULL
.	NULL

B	NULL
,	NULL
diagram	NULL
for	NULL
the	NULL
preparation	NULL
of	NULL
«	NULL
B-binding	NULL
proteins	NULL
.	NULL

The	NULL
nuclear	NULL
(	NULL
N	NULL
)	NULL
and	NULL
cytosol	NULL
(	NULL
Cy	NULL
)	NULL
extracts	NULL
were	NULL
fractionated	NULL
to	NULL
yield	NULL
NFxB	NULL
and	NULL
NFxB/I	NULL
«	NULL
B	NULL
fractions	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

protein	NULL
of	NULL
approximately	NULL
50	NULL
kDa	NULL
was	NULL
detected	NULL
with	NULL
DEO.2	NULL
{	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Cold	NULL
competition	NULL
with	NULL
unlabeled	NULL
oligonucleotides	NULL
confirmed	NULL
the	NULL
specificity	NULL
to	NULL
the	NULL
«	NULL
B	NULL
sequence	NULL
of	NULL
this	NULL
50-kDa	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
7-9	NULL
)	NULL
.	NULL

From	NULL
these	NULL
observations	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
similarities	NULL
of	NULL
the	NULL
gel	NULL
retardation	NULL
pattern	NULL
reported	NULL
previously	NULL
(	NULL
Bohnlein	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Ghosh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Meyer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
we	NULL
concluded	NULL
that	NULL
this	NULL
50-kDa	NULL
DNA-binding	NULL
protein	NULL
is	NULL
the	NULL
DNA-binding	NULL
subunit	NULL
(	NULL
p50	NULL
)	NULL
of	NULL
NF	NULL
«	NULL
B	NULL
.	NULL

Since	NULL
cys-teine-pyrimidine	NULL
pairs	NULL
are	NULL
known	NULL
to	NULL
be	NULL
the	NULL
major	NULL
product	NULL
after	NULL
UV	NULL
cross-linking	NULL
(	NULL
Smith	NULL
and	NULL
Aplin	NULL
,	NULL
1966	NULL
)	NULL
,	NULL
the	NULL
efficient	NULL
cross-linking	NULL
of	NULL
p50	NULL
to	NULL
DNA	NULL
can	NULL
be	NULL
ascribed	NULL
to	NULL
the	NULL
cysteine	NULL
residue	NULL
(	NULL
s	NULL
)	NULL
at	NULL
or	NULL
in	NULL
proximity	NULL
of	NULL
the	NULL
DNA-binding	NULL
interface	NULL
of	NULL
p50	NULL
.	NULL

We	NULL
could	NULL
not	NULL
detect	NULL
the	NULL
p65	NULL
subunit	NULL
of	NULL
NF	NULL
«	NULL
B	NULL
by	NULL
the	NULL
present	NULL
UV	NULL
cross-linking	NULL
conditions	NULL
,	NULL
probably	NULL
because	NULL
of	NULL
the	NULL
low	NULL
DNA-binding	NULL
affinity	NULL
for	NULL
p65	NULL
.	NULL

The	NULL
NF	NULL
«	NULL
B/IxB	NULL
complex	NULL
in	NULL
the	NULL
cytosolic	NULL
fractions	NULL
was	NULL
examined	NULL
by	NULL
EMSA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
detergent	NULL
mixture	NULL
(	NULL
final	NULL
concentrations	NULL
:	NULL
1.2	NULL
%	NULL
Nonidet	NULL
P-40	NULL
and	NULL
0.8	NULL
%	NULL
DOC	NULL
)	NULL
to	NULL
phys-	NULL
Redox	NULL
Regulation	NULL
of	NULL
NFxB	NULL
11383	NULL
HIV	NULL
xB	NULL
probe	NULL
__	NULL
DE	NULL
0.2	NULL
f	NULL
C	NULL
competitor	NULL
inﬁin	NULL
:	NULL
(	NULL
+	NULL
)	NULL
FT	NULL
0.1	NULL
0.15	NULL
0.2	NULL
0.3	NULL
ﬁDEAg-Swepﬂajose	NULL
Hiv	NULL
k	NULL
mag-	NULL
za	NULL
&	NULL
MK	NULL
_	NULL
<	NULL
0	NULL
(	NULL
-	NULL
)	NULL
FT	NULL
0.1	NULL
0.15	NULL
0.2	NULL
0.3	NULL
``	NULL
WT	NULL
mur	NULL
luar	NULL
grem	NULL
orp	NULL
orm	NULL
»	NULL
200	NULL
<	NULL
b2	NULL
a	NULL
[	NULL
C	NULL
W	NULL
|	NULL
n	NULL
97	NULL
69	NULL
k	NULL
_	NULL
-	NULL
50	NULL
kDa	NULL
43	NULL
30	NULL
_fn	NULL
#	NULL
s	NULL
___	NULL
1	NULL
DOC/NPA0	NULL
x8	NULL
wi	NULL
mut	NULL
Fr	NULL
.	NULL

#	NULL
:	NULL
001	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
NPs0DOC	NULL
-	NULL
$	NULL
=	NULL
k	NULL
=k	NULL
=k	NULL
=R	NULL
tk	NULL
cb	NULL
-t	NULL
-+	NULL
-+	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9101112131415	NULL
1617	NULL
18	NULL
19	NULL
20	NULL
FiG	NULL
.	NULL

2	NULL
.	NULL

Identification	NULL
of	NULL
nuclear	NULL
and	NULL
cytosolic	NULL
NF	NULL
«	NULL
B	NULL
.	NULL

A	NULL
,	NULL
DNA	NULL
binding	NULL
activities	NULL
of	NULL
the	NULL
nuclear	NULL
protein	NULL
fractions	NULL
after	NULL
separation	NULL
by	NULL
DEAE-Sepharose	NULL
column	NULL
.	NULL

The	NULL
binding	NULL
activity	NULL
to	NULL
the	NULL
HIV	NULL
«	NULL
B	NULL
probe	NULL
was	NULL
examined	NULL
by	NULL
EMSA	NULL
.	NULL

°P-End-labeled	NULL
oligonucleotide	NULL
DNA	NULL
(	NULL
HIV	NULL
wt	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
2	NULL
ul	NULL
of	NULL
each	NULL
DEAE-Sepharose	NULL
fraction	NULL
:	NULL
flow-through	NULL
(	NULL
FT	NULL
)	NULL
and	NULL
the	NULL
0.1-0.3	NULL
M	NULL
KCl	NULL
eluates	NULL
as	NULL
indicated	NULL
above	NULL
each	NULL
lane	NULL
.	NULL

The	NULL
position	NULL
of	NULL
nonspecific	NULL
protein-DNA	NULL
complex	NULL
is	NULL
indicated	NULL
by	NULL
a.	NULL
Arrowheads	NULL
b1	NULL
and	NULL
b2	NULL
indicate	NULL
the	NULL
position	NULL
of	NULL
«	NULL
B-specific	NULL
protein-DNA	NULL
complexes	NULL
.	NULL

B	NULL
,	NULL
identification	NULL
of	NULL
the	NULL
DNA-binding	NULL
subunit	NULL
of	NULL
NFxB	NULL
(	NULL
p50	NULL
)	NULL
by	NULL
UV	NULL
cross-linking	NULL
.	NULL

Each	NULL
DEAE-Sepharose	NULL
fraction	NULL
of	NULL
the	NULL
nuclear	NULL
protein	NULL
was	NULL
incubated	NULL
with	NULL
the	NULL
*P	NULL
-end-labeled	NULL
BrdU-substituted	NULL
«	NULL
B	NULL
(	NULL
HIV	NULL
WT	NULL
)	NULL
DNA	NULL
probe	NULL
.	NULL

The	NULL
cross-linked	NULL
samples	NULL
were	NULL
analyzed	NULL
by	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
.	NULL

Positions	NULL
of	NULL
molecular	NULL
size	NULL
makers	NULL
in	NULL
kDa	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
left	NULL
.	NULL

The	NULL
position	NULL
of	NULL
the	NULL
50-kDa	NULL
protein	NULL
complex	NULL
is	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
no	NULL
protein	NULL
was	NULL
added	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
flow-through	NULL
(	NULL
FT	NULL
)	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
DEO.1	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
DEO.15	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
DEO.2	NULL
;	NULL
lane	NULL
6	NULL
,	NULL
DEO.3	NULL
.	NULL

Specificity	NULL
of	NULL
the	NULL
DNA-protein	NULL
interaction	NULL
with	NULL
DEO.2	NULL
was	NULL
examined	NULL
by	NULL
premixing	NULL
with	NULL
a	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
cold	NULL
competitor	NULL
DNAs	NULL
:	NULL
wild	NULL
type	NULL
«	NULL
B	NULL
sequences	NULL
(	NULL
lane	NULL
7	NULL
,	NULL
HIV	NULL
«	NULL
B	NULL
(	NULL
wild	NULL
type	NULL
)	NULL
;	NULL
lane	NULL
9	NULL
,	NULL
IL-2Ra	NULL
)	NULL
and	NULL
its	NULL
mutant	NULL
(	NULL
lane	NULL
8	NULL
,	NULL
HIV	NULL
«	NULL
B	NULL
(	NULL
mut	NULL
)	NULL
)	NULL
.	NULL

C	NULL
,	NULL
demonstration	NULL
of	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
in	NULL
fractions	NULL
from	NULL
the	NULL
preparative	NULL
glycerol	NULL
gradient	NULL
centrifugation	NULL
.	NULL

Left	NULL
,	NULL
NF	NULL
«	NULL
B-I	NULL
«	NULL
B	NULL
complex	NULL
was	NULL
identified	NULL
by	NULL
adding	NULL
0.8	NULL
%	NULL
DOC	NULL
and	NULL
1.2	NULL
%	NULL
Nonidet	NULL
P-40	NULL
.	NULL

In	NULL
even-numbered	NULL
lanes	NULL
,	NULL
the	NULL
detergents	NULL
were	NULL
added	NULL
into	NULL
the	NULL
reaction	NULL
mixture	NULL
(	NULL
+	NULL
)	NULL
,	NULL
but	NULL
in	NULL
odd-numbered	NULL
lanes	NULL
,	NULL
they	NULL
were	NULL
not	NULL
added	NULL
(	NULL
-	NULL
)	NULL
.	NULL

The	NULL
neighboring	NULL
two	NULL
lanes	NULL
are	NULL
from	NULL
the	NULL
same	NULL
fraction	NULL
(	NULL
fraction	NULL
numbers	NULL
are	NULL
indicated	NULL
on	NULL
top	NULL
)	NULL
.	NULL

The	NULL
closed	NULL
triangles	NULL
indicate	NULL
the	NULL
NFxB-DNA	NULL
complexes	NULL
,	NULL
and	NULL
the	NULL
open	NULL
triangle	NULL
indicates	NULL
the	NULL
free	NULL
probe	NULL
.	NULL

Right	NULL
,	NULL
specificity	NULL
for	NULL
the	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
in	NULL
the	NULL
glycerol	NULL
gradient	NULL
fraction	NULL
number	NULL
3	NULL
(	NULL
Fr	NULL
.	NULL

#	NULL
3	NULL
)	NULL
.	NULL

After	NULL
treatment	NULL
with	NULL
DOC/Nonidet	NULL
P-40	NULL
,	NULL
fraction	NULL
3	NULL
was	NULL
premixed	NULL
with	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
cold	NULL
competitors	NULL
.	NULL

Asterisk	NULL
indicates	NULL
the	NULL
position	NULL
of	NULL
a	NULL
nonspecific	NULL
band	NULL
.	NULL

ically	NULL
dissociate	NULL
IxB	NULL
from	NULL
NF	NULL
«	NULL
B	NULL
.	NULL

The	NULL
NF	NULL
«	NULL
B	NULL
activity	NULL
was	NULL
demonstrated	NULL
in	NULL
two	NULL
consecutive	NULL
fractions	NULL
from	NULL
the	NULL
glycerol	NULL
density	NULL
gradient	NULL
centrifugation	NULL
,	NULL
fractions	NULL
2	NULL
and	NULL
3	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
left	NULL
)	NULL
.	NULL

The	NULL
mobility	NULL
of	NULL
DNA-protein	NULL
complex	NULL
was	NULL
identical	NULL
to	NULL
the	NULL
nuclear	NULL
NF	NULL
«	NULL
B	NULL
(	NULL
lower	NULL
band	NULL
)	NULL
.	NULL

Cold	NULL
competition	NULL
experiments	NULL
again	NULL
demonstrated	NULL
the	NULL
sequence-specific	NULL
DNA-binding	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
right	NULL
)	NULL
.	NULL

We	NULL
also	NULL
performed	NULL
in	NULL
vitro	NULL
phosphoryla-tion	NULL
with	NULL
purified	NULL
PKC	NULL
.	NULL

When	NULL
increasing	NULL
amounts	NULL
of	NULL
PKC	NULL
was	NULL
added	NULL
to	NULL
fractions	NULL
2	NULL
or	NULL
3	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
«	NULL
B-binding	NULL
activity	NULL
was	NULL
observed	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

From	NULL
these	NULL
observations	NULL
,	NULL
we	NULL
concluded	NULL
that	NULL
fractions	NULL
2	NULL
and	NULL
3	NULL
contained	NULL
the	NULL
NF	NULL
«	NULL
B/IxB	NULL
complex	NULL
.	NULL

Redox	NULL
Regulation	NULL
of	NULL
the	NULL
DNA	NULL
Binding	NULL
Activity	NULL
of	NULL
NF	NULL
«	NULL
B	NULL
by	NULL
Human	NULL
Thioredoxin	NULL
(	NULL
Trx	NULL
)	NULL
-The	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
the	NULL
nuclear	NULL
and	NULL
the	NULL
cytosolic	NULL
NF	NULL
«	NULL
B	NULL
was	NULL
examined	NULL
upon	NULL
oxidoreductive	NULL
modifications	NULL
of	NULL
sulfhydryls	NULL
on	NULL
the	NULL
cysteine	NULL
residues	NULL
11384	NULL
by	NULL
various	NULL
oxidizing	NULL
or	NULL
reducing	NULL
reagents	NULL
.	NULL

First	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
oxidation	NULL
and	NULL
reduction	NULL
of	NULL
the	NULL
nuclear	NULL
NFxB	NULL
were	NULL
examined	NULL
.	NULL

Fig	NULL
.	NULL

3	NULL
demonstrates	NULL
the	NULL
representative	NULL
results	NULL
obtained	NULL
with	NULL
the	NULL
nuclear	NULL
NF	NULL
«	NULL
B	NULL
.	NULL

When	NULL
the	NULL
DEO.2	NULL
fraction	NULL
containing	NULL
the	NULL
nuclear	NULL
NF	NULL
«	NULL
B	NULL
was	NULL
treated	NULL
with	NULL
diamide	NULL
,	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
totally	NULL
abolished	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
subsequent	NULL
addition	NULL
to	NULL
10	NULL
mM	NULL
DTT	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
or	NULL
2-ME	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
fully	NULL
restored	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NFxB	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
reduction	NULL
by	NULL
Trx	NULL
(	NULL
20	NULL
uM	NULL
,	NULL
reduced	NULL
form	NULL
)	NULL
was	NULL
demonstrated	NULL
with	NULL
much	NULL
greater	NULL
efficiency	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

We	NULL
then	NULL
examined	NULL
whether	NULL
T'rx	NULL
requires	NULL
the	NULL
proton	NULL
recruitment	NULL
in	NULL
reactivating	NULL
the	NULL
oxidized	NULL
NFxB	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lames	NULL
5	NULL
,	NULL
7	NULL
,	NULL
and	NULL
9-13	NULL
)	NULL
.	NULL

The	NULL
reducing	NULL
activity	NULL
of	NULL
T'rx	NULL
appeared	NULL
to	NULL
require	NULL
proton	NULL
recruitment	NULL
from	NULL
NADPH	NULL
through	NULL
Trx-reductase	NULL
(	NULL
TxR	NULL
)	NULL
,	NULL
since	NULL
omission	NULL
of	NULL
one	NULL
component	NULL
from	NULL
the	NULL
T'rx	NULL
system	NULL
,	NULL
either	NULL
NADPH	NULL
,	NULL
T'xR	NULL
,	NULL
or	NULL
T'rx	NULL
itself	NULL
,	NULL
did	NULL
not	NULL
support	NULL
restoration	NULL
of	NULL
the	NULL
NFxB	NULL
activity	NULL
,	NULL
whereas	NULL
a	NULL
complete	NULL
Trx	NULL
system	NULL
effi-	NULL
HIV	NULL
xB	NULL
probe	NULL
DEO	NULL
2	NULL
fraction	NULL
Diamide	NULL
1	NULL
mM	NULL
T	NULL
&	NULL
R	NULL
NADPH	NULL
TxR	NULL
+	NULL
NADPH	NULL
reduced	NULL
+	NULL
+f	NULL
msl	NULL
1	NULL
DTT	NULL
NADPH	NULL
TRX	NULL
TRX	NULL
mTRX	NULL
TRX	NULL
TRX	NULL
TRX	NULL
TRX	NULL
TRX	NULL
mTRX	NULL
mTRX	NULL
mTRX	NULL
(	NULL
20	NULL
)	NULL
(	NULL
20	NULL
)	NULL
(	NULL
20	NULL
)	NULL
(	NULL
20	NULL
)	NULL
(	NULL
20	NULL
)	NULL
(	NULL
1	NULL
)	NULL
(	NULL
6	NULL
)	NULL
(	NULL
20	NULL
)	NULL
(	NULL
)	NULL
®	NULL
)	NULL
(	NULL
@	NULL
)	NULL
on	NULL
tinny	NULL
ire	NULL
»	NULL
i	NULL
-	NULL
w	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
1112	NULL
13	NULL
14	NULL
1516	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Oxidoreductive	NULL
modulations	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NFx	NULL
«	NULL
B	NULL
and	NULL
the	NULL
effect	NULL
of	NULL
Trx	NULL
system	NULL
.	NULL

The	NULL
nuclear	NULL
NF	NULL
«	NULL
B	NULL
(	NULL
DEO.2	NULL
from	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
was	NULL
treated	NULL
with	NULL
the	NULL
oxidizing	NULL
agent	NULL
diamide	NULL
,	NULL
and	NULL
activities	NULL
of	NULL
various	NULL
reducing	NULL
agents	NULL
were	NULL
examined	NULL
for	NULL
the	NULL
ability	NULL
to	NULL
restore	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

Oxidation	NULL
was	NULL
performed	NULL
by	NULL
1	NULL
mM	NULL
(	NULL
final	NULL
concentration	NULL
)	NULL
of	NULL
diamide	NULL
on	NULL
ice	NULL
for	NULL
5	NULL
min	NULL
.	NULL

Reduction	NULL
with	NULL
various	NULL
reducing	NULL
agents	NULL
including	NULL
the	NULL
Trx	NULL
system	NULL
was	NULL
performed	NULL
at	NULL
30	NULL
°C	NULL
for	NULL
5	NULL
min	NULL
.	NULL

The	NULL
oxidized	NULL
NFxB	NULL
was	NULL
treated	NULL
by	NULL
10	NULL
mm	NULL
DTT	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
NADPH	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
20	NULL
um	NULL
fully	NULL
reduced	NULL
Trx	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
20	NULL
uM	NULL
Trx	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
20	NULL
uM	NULL
mutant	NULL
Trx	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
,	NULL
Trx	NULL
and	NULL
Trx-reductase	NULL
purified	NULL
from	NULL
rabbit	NULL
liver	NULL
(	NULL
TxR	NULL
)	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
,	NULL
or	NULL
Trx	NULL
and	NULL
1	NULL
mm	NULL
NADPH	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
.	NULL

In	NULL
lanes	NULL
11-16	NULL
,	NULL
various	NULL
concentrations	NULL
(	NULL
1	NULL
,	NULL
5	NULL
,	NULL
and	NULL
20	NULL
um	NULL
)	NULL
of	NULL
Trx	NULL
(	NULL
lanes	NULL
11-13	NULL
)	NULL
and	NULL
its	NULL
inactive	NULL
mutant	NULL
(	NULL
mTrx	NULL
)	NULL
(	NULL
lanes	NULL
14-16	NULL
)	NULL
was	NULL
added	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
fully	NULL
competent	NULL
Trx-reducing	NULL
system	NULL
,	NULL
TxR	NULL
and	NULL
NADPH	NULL
.	NULL

Redox	NULL
Regulation	NULL
of	NULL
NFxB	NULL
ciently	NULL
restored	NULL
the	NULL
NFxB	NULL
activity	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
for	NULL
Trx	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lanes	NULL
11-13	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
mutant	NULL
Trx	NULL
(	NULL
a	NULL
single	NULL
amino	NULL
acid	NULL
replacement	NULL
of	NULL
the	NULL
catalytic	NULL
active	NULL
center	NULL
cysteine	NULL
31	NULL
by	NULL
serine	NULL
)	NULL
(	NULL
Mitsui	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
failed	NULL
to	NULL
recover	NULL
the	NULL
NF	NULL
«	NULL
B	NULL
activity	NULL
even	NULL
with	NULL
the	NULL
Trx-regenerating	NULL
system	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lanes	NULL
8	NULL
and	NULL
14-16	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
indicate	NULL
that	NULL
Trx	NULL
restores	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
the	NULL
oxidized	NULL
NF	NULL
«	NULL
B	NULL
by	NULL
facilitating	NULL
proton	NULL
transfer	NULL
to	NULL
the	NULL
disulfides	NULL
on	NULL
NFxB	NULL
molecule	NULL
through	NULL
its	NULL
catalytic	NULL
action	NULL
.	NULL

Redox	NULL
Regulation	NULL
of	NULL
the	NULL
Cytosolic	NULL
NFB	NULL
by	NULL
Trx	NULL
and	NULL
the	NULL
Relationship	NULL
with	NULL
the	NULL
Signal	NULL
Pathway	NULL
Involving	NULL
Dissociation	NULL
of	NULL
IxB-Similarly	NULL
,	NULL
we	NULL
evaluated	NULL
redox	NULL
regulation	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
with	NULL
the	NULL
cytosolic	NULL
NF	NULL
«	NULL
B	NULL
(	NULL
Figs	NULL
.	NULL

4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

In	NULL
these	NULL
experiments	NULL
,	NULL
the	NULL
NF	NULL
«	NULL
B/IkB	NULL
complex	NULL
in	NULL
a	NULL
cytosolic	NULL
fraction	NULL
,	NULL
fraction	NULL
3	NULL
,	NULL
was	NULL
first	NULL
treated	NULL
by	NULL
detergents	NULL
(	NULL
deoxycho-late	NULL
and	NULL
Nonidet	NULL
P-40	NULL
)	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

2C	NULL
and	NULL
the	NULL
effects	NULL
of	NULL
oxidoreductive	NULL
modifications	NULL
were	NULL
examined	NULL
.	NULL

The	NULL
cytosolic	NULL
NFxB	NULL
,	NULL
showing	NULL
strong	NULL
binding	NULL
to	NULL
the	NULL
xB	NULL
DNA	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
lost	NULL
its	NULL
activity	NULL
by	NULL
oxidation	NULL
with	NULL
diamide	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Effects	NULL
of	NULL
Trx	NULL
in	NULL
restoring	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
the	NULL
oxidized	NULL
cytosolic	NULL
NF	NULL
«	NULL
B	NULL
was	NULL
also	NULL
evident	NULL
(	NULL
lanes	NULL
8-10	NULL
)	NULL
.	NULL

The	NULL
full	NULL
components	NULL
of	NULL
the	NULL
Trx	NULL
system	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
lanes	NULL
8-10	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
reduced	NULL
form	NULL
of	NULL
T'rx	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
restored	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
the	NULL
oxidized	NULL
NFxB	NULL
.	NULL

The	NULL
relative	NULL
activity	NULL
of	NULL
T'rx	NULL
in	NULL
restoring	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF	NULL
«	NULL
B	NULL
was	NULL
about	NULL
500-fold	NULL
greater	NULL
than	NULL
2-ME	NULL
or	NULL
DTT	NULL
,	NULL
since	NULL
20	NULL
uM	NULL
Trx	NULL
had	NULL
nearly	NULL
the	NULL
same	NULL
activity	NULL
as	NULL
10	NULL
mM	NULL
DTT	NULL
(	NULL
compare	NULL
lanes	NULL
4	NULL
and	NULL
13	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
or	NULL
10	NULL
mM	NULL
2-ME	NULL
(	NULL
compare	NULL
lanes	NULL
8	NULL
and	NULL
12	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

However	NULL
,	NULL
either	NULL
oxidation	NULL
or	NULL
reduction	NULL
alone	NULL
could	NULL
not	NULL
dissociate	NULL
the	NULL
cytosolic	NULL
NFxB	NULL
from	NULL
the	NULL
NF	NULL
«	NULL
B/	NULL
I	NULL
«	NULL
B	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
lanes	NULL
1-3	NULL
)	NULL
.	NULL

We	NULL
then	NULL
investigated	NULL
the	NULL
hierarchy	NULL
of	NULL
actions	NULL
of	NULL
these	NULL
two	NULL
modalities	NULL
in	NULL
regulating	NULL
the	NULL
NF	NULL
«	NULL
B	NULL
activity	NULL
:	NULL
dissociation	NULL
of	NULL
I	NULL
«	NULL
B	NULL
from	NULL
the	NULL
NF	NULL
«	NULL
B	NULL
I	NULL
«	NULL
B	NULL
complex	NULL
and	NULL
the	NULL
redox	NULL
regulation	NULL
by	NULL
Trx	NULL
.	NULL

In	NULL
lanes	NULL
3-14	NULL
of	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
the	NULL
cytosolic	NULL
fraction	NULL
3	NULL
containing	NULL
the	NULL
NF	NULL
«	NULL
B-I	NULL
«	NULL
B	NULL
complex	NULL
was	NULL
first	NULL
oxidized	NULL
by	NULL
diamide	NULL
.	NULL

When	NULL
we	NULL
reduced	NULL
the	NULL
oxidized	NULL
NF	NULL
«	NULL
B	NULL
-IxB	NULL
complex	NULL
by	NULL
the	NULL
T'rx	NULL
system	NULL
prior	NULL
to	NULL
dissociation	NULL
of	NULL
IxB	NULL
by	NULL
the	NULL
detergents	NULL
,	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
not	NULL
recovered	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
4-6	NULL
and	NULL
9	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
Trx	NULL
system	NULL
in	NULL
recovering	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
the	NULL
oxidized	NULL
NF	NULL
«	NULL
B	NULL
was	NULL
evident	NULL
when	NULL
I	NULL
«	NULL
xB	NULL
had	NULL
been	NULL
dissociated	NULL
prior	NULL
to	NULL
the	NULL
reduction	NULL
by	NULL
the	NULL
Trx	NULL
system	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
11-13	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
when	NULL
we	NULL
used	NULL
2-ME	NULL
for	NULL
reduction	NULL
,	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF	NULL
«	NULL
B	NULL
was	NULL
recovered	NULL
even	NULL
when	NULL
we	NULL
added	NULL
2-ME	NULL
before	NULL
treatment	NULL
with	NULL
the	NULL
detergent	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
8	NULL
and	NULL
10	NULL
)	NULL
.	NULL

These	NULL
differences	NULL
of	NULL
action	NULL
of	NULL
Trx	NULL
and	NULL
2-ME	NULL
were	NULL
probably	NULL
due	NULL
to	NULL
the	NULL
differences	NULL
in	NULL
their	NULL
accessibility	NULL
to	NULL
the	NULL
oxidized	NULL
disulfide	NULL
(	NULL
s	NULL
)	NULL
on	NULL
p50	NULL
.	NULL

Since	NULL
the	NULL
molecular	NULL
mass	NULL
of	NULL
2-	NULL
ME	NULL
is	NULL
only	NULL
78	NULL
daltons	NULL
,	NULL
whereas	NULL
Trx	NULL
is	NULL
approximately	NULL
13,000	NULL
daltons	NULL
(	NULL
Tagaya	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
2-ME	NULL
,	NULL
not	NULL
T'rx	NULL
,	NULL
can	NULL
reach	NULL
the	NULL
target	NULL
disulfide	NULL
(	NULL
s	NULL
)	NULL
on	NULL
p50	NULL
that	NULL
is	NULL
incompletely	NULL
masked	NULL
by	NULL
the	NULL
associating	NULL
molecule	NULL
IxB	NULL
.	NULL

From	NULL
these	NULL
results	NULL
,	NULL
we	NULL
concluded	NULL
that	NULL
Trx	NULL
might	NULL
act	NULL
on	NULL
NFxB	NULL
only	NULL
after	NULL
the	NULL
dissociation	NULL
of	NULL
IxB	NULL
and	NULL
that	NULL
this	NULL
order	NULL
of	NULL
action	NULL
might	NULL
be	NULL
determined	NULL
based	NULL
on	NULL
the	NULL
lack	NULL
of	NULL
accessibility	NULL
of	NULL
Trx	NULL
to	NULL
reach	NULL
the	NULL
oxidized	NULL
disulfide	NULL
(	NULL
s	NULL
)	NULL
on	NULL
the	NULL
NF	NULL
«	NULL
B	NULL
when	NULL
associated	NULL
with	NULL
IB	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
of	NULL
the	NULL
cytosolic	NULL
NF	NULL
«	NULL
B	NULL
with	NULL
its	NULL
natural	NULL
form	NULL
within	NULL
the	NULL
intact	NULL
cells	NULL
,	NULL
we	NULL
prepared	NULL
the	NULL
cytosolic	NULL
NFB	NULL
-IxB	NULL
complex	NULL
with	NULL
all	NULL
the	NULL
buffers	NULL
deaerated	NULL
and	NULL
replaced	NULL
by	NULL
nitrogen	NULL
gas	NULL
and	NULL
without	NULL
using	NULL
any	NULL
artificial	NULL
reductant	NULL
(	NULL
performed	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Each	NULL
cytosolic	NULL
fraction	NULL
from	NULL
glycerol	NULL
density	NULL
gradient	NULL
was	NULL
first	NULL
treated	NULL
with	NULL
Nonidet	NULL
P-40	NULL
and	NULL
DOC	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Unlike	NULL
the	NULL
result	NULL
in	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
we	NULL
could	NULL
not	NULL
detect	NULL
any	NULL
«	NULL
kB	NULL
binding	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
when	NULL
we	NULL
further	NULL
reduced	NULL
the	NULL
proteins	NULL
by	NULL
the	NULL
Trx	NULL
system	NULL
,	NULL
the	NULL
«	NULL
B	NULL
Redox	NULL
Regulation	NULL
of	NULL
NFB	NULL
A	NULL
DOC	NULL
+	NULL
NP40	NULL
NADPH	NULL
I	NULL
Diam	NULL
1	NULL
+	NULL
f	NULL
T	NULL
TxR	NULL
NADPH	NULL
NADPH	NULL
(	NULL
+	NULL
)	NULL
+	NULL
+-	NULL
reduced	NULL
__	NULL
TXR	NULL
(	NULL
+	NULL
)	NULL
Diamide	NULL
TRX	NULL
TRX	NULL
TxA	NULL
TRX	NULL
``	NULL
~-	NULL
TAX	NULL
ImTRx	NULL
``	NULL
--	NULL
2ME	NULL
(	NULL
20	NULL
)	NULL
(	NULL
20	NULL
)	NULL
(	NULL
20	NULL
)	NULL
(	NULL
20	NULL
)	NULL
(	NULL
5	NULL
)	NULL
(	NULL
1	NULL
)	NULL
(	NULL
20	NULL
)	NULL
(	NULL
10	NULL
)	NULL
(	NULL
50	NULL
)	NULL
(	NULL
200	NULL
)	NULL
ipm	NULL
s	NULL
I	NULL
A	NULL
«	NULL
«	NULL
»	NULL
A	NULL
1	NULL
2	NULL
3	NULL
4	NULL
50	NULL
60	NULL
7	NULL
8	NULL
9g	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
B	NULL
Diamide	NULL
f	NULL
TRX	NULL
wt	NULL
___	NULL
mut	NULL
2-ME	NULL
DOG	NULL
.	NULL

NP40	NULL
'	NULL
``	NULL
zo	NULL
_s	NULL
1	NULL
``	NULL
20	NULL
‘	NULL
mMHRXrLMH	NULL
TRX	NULL
wi	NULL
mut	NULL
!	NULL

DOC	NULL
+	NULL
NP40	NULL
20	NULL
``	NULL
1	NULL
mm	NULL
20	NULL
50	NULL
1	NULL
'	NULL
20	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
FiG	NULL
.	NULL

4	NULL
.	NULL

Oxidoreductive	NULL
modulations	NULL
of	NULL
the	NULL
cytosolic	NULL
NFx	NULL
«	NULL
B	NULL
.	NULL

A	NULL
,	NULL
a	NULL
cytosolic	NULL
fraction	NULL
containing	NULL
the	NULL
NFxB	NULL
IB	NULL
complex	NULL
(	NULL
fraction	NULL
3	NULL
)	NULL
was	NULL
treated	NULL
by	NULL
the	NULL
detergents	NULL
to	NULL
dissociate	NULL
IxB	NULL
from	NULL
the	NULL
NF	NULL
«	NULL
B	NULL
-	NULL
IxB	NULL
complex	NULL
.	NULL

Oxidation	NULL
by	NULL
diamide	NULL
and	NULL
the	NULL
reduction	NULL
by	NULL
T'rx	NULL
system	NULL
was	NULL
performed	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Direct	NULL
oxidation	NULL
of	NULL
fraction	NULL
3	NULL
by	NULL
diamide	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
reduction	NULL
by	NULL
Trx	NULL
(	NULL
lane	NULL
2	NULL
,	NULL
Trx	NULL
alone	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
full	NULL
component	NULL
of	NULL
Trx	NULL
system	NULL
)	NULL
did	NULL
not	NULL
activate	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

In	NULL
lanes	NULL
4-14	NULL
,	NULL
fraction	NULL
3	NULL
was	NULL
first	NULL
treated	NULL
by	NULL
the	NULL
detergents	NULL
and	NULL
then	NULL
oxidized	NULL
by	NULL
1	NULL
mM	NULL
diamide	NULL
.	NULL

Oxidized	NULL
proteins	NULL
were	NULL
then	NULL
treated	NULL
by	NULL
various	NULL
11385	NULL
binding	NULL
activity	NULL
was	NULL
demonstrated	NULL
in	NULL
fractions	NULL
2	NULL
and	NULL
3	NULL
,	NULL
and	NULL
slightly	NULL
in	NULL
fraction	NULL
4	NULL
,	NULL
as	NULL
demonstrated	NULL
in	NULL
Fig	NULL
.	NULL

2C	NULL
.	NULL

Although	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
a	NULL
possibility	NULL
that	NULL
NFxB	NULL
might	NULL
have	NULL
been	NULL
oxidized	NULL
during	NULL
the	NULL
preparation	NULL
,	NULL
this	NULL
kind	NULL
of	NULL
experiment	NULL
was	NULL
necessary	NULL
to	NULL
verify	NULL
the	NULL
biological	NULL
relevance	NULL
of	NULL
the	NULL
redox	NULL
regulation	NULL
of	NULL
NFB	NULL
.	NULL

We	NULL
then	NULL
compared	NULL
the	NULL
ability	NULL
of	NULL
various	NULL
reducing	NULL
catalysts	NULL
,	NULL
including	NULL
DTT	NULL
,	NULL
2-ME	NULL
,	NULL
Trx	NULL
,	NULL
and	NULL
GSH	NULL
,	NULL
in	NULL
activating	NULL
the	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Among	NULL
these	NULL
reductants	NULL
Trx	NULL
showed	NULL
the	NULL
highest	NULL
efficiency	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
GSH	NULL
even	NULL
with	NULL
higher	NULL
concentration	NULL
and	NULL
together	NULL
with	NULL
its	NULL
regenerating	NULL
system	NULL
did	NULL
not	NULL
show	NULL
any	NULL
activity	NULL
.	NULL

These	NULL
results	NULL
were	NULL
consistent	NULL
with	NULL
the	NULL
results	NULL
obtained	NULL
with	NULL
the	NULL
diamide-oxidized	NULL
NFxB	NULL
that	NULL
was	NULL
prepared	NULL
from	NULL
the	NULL
cells	NULL
using	NULL
DTT	NULL
.	NULL

Activation	NULL
of	NULL
HIV	NULL
Gene	NULL
Expression	NULL
by	NULL
Trx	NULL
in	NULL
Cell	NULL
Culture	NULL
System	NULL
Using	NULL
Transient	NULL
CAT	NULL
Assay-We	NULL
carried	NULL
out	NULL
transient	NULL
CAT	NULL
assay	NULL
to	NULL
confirm	NULL
the	NULL
effects	NULL
of	NULL
Trx	NULL
on	NULL
NFx	NULL
«	NULL
B	NULL
in	NULL
cell-free	NULL
DNA-binding	NULL
assays	NULL
.	NULL

We	NULL
used	NULL
CAT	NULL
-expression	NULL
plasmids	NULL
under	NULL
the	NULL
control	NULL
of	NULL
HIV	NULL
LTR	NULL
,	NULL
either	NULL
wild	NULL
type	NULL
or	NULL
its	NULL
mutant	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
mutant	NULL
construct	NULL
contains	NULL
substitutions	NULL
in	NULL
the	NULL
two	NULL
tandemly	NULL
repeated	NULL
«	NULL
B	NULL
sequence	NULL
,	NULL
so	NULL
that	NULL
NF	NULL
«	NULL
B	NULL
can	NULL
no	NULL
longer	NULL
recognize	NULL
the	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

Either	NULL
of	NULL
these	NULL
plasmids	NULL
was	NULL
transfected	NULL
to	NULL
COS-1	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
or	NULL
Jurkat	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
cells	NULL
in	NULL
combination	NULL
with	NULL
a	NULL
Trx-expressing	NULL
plasmid	NULL
,	NULL
SRa	NULL
«	NULL
ADF	NULL
(	NULL
Tagaya	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
,	NULL
or	NULL
with	NULL
the	NULL
vector	NULL
control	NULL
,	NULL
SRaNeo	NULL
.	NULL

We	NULL
harvested	NULL
the	NULL
cells	NULL
24-60	NULL
h	NULL
after	NULL
transfection	NULL
and	NULL
prepared	NULL
the	NULL
cell	NULL
lysates	NULL
for	NULL
CAT	NULL
enzyme	NULL
assays	NULL
.	NULL

As	NULL
demonstrated	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
(	NULL
B	NULL
and	NULL
C	NULL
)	NULL
,	NULL
CAT	NULL
gene	NULL
expression	NULL
from	NULL
the	NULL
wild	NULL
type	NULL
HIV	NULL
LTR	NULL
was	NULL
greatly	NULL
stimulated	NULL
(	NULL
greater	NULL
than	NULL
4-fold	NULL
for	NULL
Jurkat	NULL
cells	NULL
and	NULL
nearly	NULL
13-fold	NULL
for	NULL
COS-1	NULL
cells	NULL
)	NULL
by	NULL
co-transfection	NULL
of	NULL
SRaADF	NULL
plasmid	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
CAT	NULL
expression	NULL
from	NULL
the	NULL
mutant	NULL
HIV	NULL
LTR	NULL
was	NULL
not	NULL
stimulated	NULL
by	NULL
cotransfection	NULL
with	NULL
SRaADF	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
was	NULL
concluded	NULL
that	NULL
Trx	NULL
could	NULL
stimulate	NULL
HIV	NULL
gene	NULL
expression	NULL
through	NULL
NF	NULL
«	NULL
B	NULL
in	NULL
cultured	NULL
cells	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
report	NULL
we	NULL
demonstrate	NULL
that	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
an	NULL
inducible	NULL
transcription	NULL
factor	NULL
,	NULL
NF	NULL
«	NULL
B	NULL
,	NULL
prepared	NULL
from	NULL
the	NULL
nucleus	NULL
or	NULL
from	NULL
the	NULL
cytoplasm	NULL
,	NULL
is	NULL
regulated	NULL
by	NULL
a	NULL
cellular	NULL
reducing	NULL
catalyst	NULL
T'rx	NULL
through	NULL
redox	NULL
control	NULL
mechanism	NULL
.	NULL

T'rx	NULL
appears	NULL
to	NULL
modulate	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
by	NULL
dithiol-disulfide	NULL
exchange	NULL
reaction	NULL
.	NULL

By	NULL
using	NULL
the	NULL
cell-free	NULL
system	NULL
and	NULL
the	NULL
transient	NULL
CAT	NULL
gene	NULL
expression	NULL
system	NULL
with	NULL
intact	NULL
cells	NULL
we	NULL
were	NULL
able	NULL
to	NULL
show	NULL
that	NULL
Trx	NULL
activates	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF	NULL
«	NULL
B	NULL
and	NULL
augments	NULL
gene	NULL
expression	NULL
from	NULL
HIV	NULL
LTR	NULL
in	NULL
an	NULL
NFx	NULL
«	NULL
B-dependent	NULL
manner	NULL
.	NULL

Similar	NULL
findings	NULL
have	NULL
been	NULL
shown	NULL
by	NULL
Matthews	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
using	NULL
transient	NULL
CAT	NULL
expression	NULL
under	NULL
HIV	NULL
LTR	NULL
in	NULL
COS	NULL
cells	NULL
.	NULL

They	NULL
also	NULL
demon	NULL
reducing	NULL
agents	NULL
:	NULL
TxR	NULL
and	NULL
1	NULL
mm	NULL
NADPH	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
fully	NULL
reduced	NULL
Trx	NULL
at	NULL
20	NULL
um	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
mutant	NULL
Trx	NULL
(	NULL
lane	NULL
11	NULL
)	NULL
,	NULL
and	NULL
full	NULL
component	NULL
of	NULL
Trx	NULL
system	NULL
with	NULL
Trx	NULL
concentrations	NULL
of	NULL
20	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
,	NULL
5	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
,	NULL
or	NULL
1	NULL
uM	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
inorganic	NULL
reductant	NULL
2-ME	NULL
was	NULL
also	NULL
examined	NULL
(	NULL
lane	NULL
12	NULL
,	NULL
10	NULL
mM	NULL
;	NULL
lane	NULL
13	NULL
,	NULL
50	NULL
mM	NULL
;	NULL
lane	NULL
14	NULL
,	NULL
200	NULL
mm	NULL
)	NULL
.	NULL

B	NULL
,	NULL
effects	NULL
of	NULL
the	NULL
order	NULL
of	NULL
treatments	NULL
:	NULL
oxidoreductive	NULL
modifications	NULL
and	NULL
dissociation	NULL
of	NULL
IxB	NULL
.	NULL

Lanes	NULL
3-14	NULL
,	NULL
the	NULL
cytosolic	NULL
NFx	NULL
«	NULL
B	NULL
fraction	NULL
(	NULL
fraction	NULL
3	NULL
)	NULL
was	NULL
first	NULL
oxidized	NULL
by	NULL
diamide	NULL
.	NULL

The	NULL
diamide-oxidized	NULL
NFxB/IxB	NULL
was	NULL
either	NULL
immediately	NULL
reduced	NULL
(	NULL
lanes	NULL
4-10	NULL
)	NULL
or	NULL
reduced	NULL
after	NULL
the	NULL
treatment	NULL
with	NULL
the	NULL
detergents	NULL
(	NULL
lanes	NULL
11-14	NULL
)	NULL
.	NULL

Lanes	NULL
4-7	NULL
,	NULL
the	NULL
oxidized	NULL
proteins	NULL
were	NULL
reduced	NULL
by	NULL
the	NULL
Trx	NULL
system	NULL
and	NULL
then	NULL
treated	NULL
by	NULL
the	NULL
detergents	NULL
to	NULL
dissociate	NULL
IxB	NULL
.	NULL

Lanes	NULL
11-14	NULL
,	NULL
the	NULL
oxidized	NULL
proteins	NULL
were	NULL
treated	NULL
by	NULL
the	NULL
detergents	NULL
and	NULL
then	NULL
reduced	NULL
by	NULL
the	NULL
T'rx	NULL
system	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
probe	NULL
alone	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
positive	NULL
control	NULL
(	NULL
fraction	NULL
3	NULL
treated	NULL
by	NULL
DOC/Nonidet	NULL
P-40	NULL
)	NULL
;	NULL
lane	NULL
8	NULL
,	NULL
1	NULL
mm	NULL
2-ME	NULL
was	NULL
used	NULL
instead	NULL
of	NULL
Trx	NULL
;	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
,	NULL
Trx	NULL
or	NULL
2ME	NULL
were	NULL
added	NULL
without	NULL
further	NULL
treatment	NULL
with	NULL
DOC/Nonidet	NULL
P-40	NULL
;	NULL
lanes	NULL
7	NULL
and	NULL
14	NULL
,	NULL
mutant	NULL
Trx	NULL
was	NULL
used	NULL
instead	NULL
of	NULL
wild	NULL
type	NULL
Trx	NULL
.	NULL

Concentration	NULL
of	NULL
diamide	NULL
used	NULL
was	NULL
1	NULL
mM	NULL
.	NULL

Concentrations	NULL
of	NULL
Trx	NULL
(	NULL
in	NULL
uM	NULL
)	NULL
were	NULL
indicated	NULL
.	NULL

The	NULL
position	NULL
of	NULL
a	NULL
nonspecific	NULL
band	NULL
was	NULL
indicated	NULL
by	NULL
an	NULL
asterisk	NULL
.	NULL

A	NULL
+	NULL
NP40/D0C	NULL
F-	NULL
e	NULL
Fr	NULL
#	NULL
O10	NULL
20	NULL
OB	NULL
4	NULL
50	NULL
060	NULL
7	NULL
os	NULL
9	NULL
40	NULL
~	NULL
+	NULL
-+	NULL
-	NULL
4+	NULL
-	NULL
+	NULL
-+	NULL
-+	NULL
-+	NULL
-+	NULL
-+	NULL
-+	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9101112131415	NULL
1617	NULL
1819	NULL
20	NULL
Fr	NULL
.	NULL

#	NULL
2	NULL
+	NULL
NP40/D00C	NULL
NADPH	NULL
GR	NULL
+	NULL
NADPH	NULL
DTT	NULL
2-ME	NULL
TRX	NULL
TRX	NULL
«	NULL
reduced	NULL
GSH	NULL
10mM	NULL
10mM	NULL
(	NULL
wt	NULL
)	NULL
(	NULL
mut	NULL
)	NULL
_	NULL
GSH	NULL
20	NULL
20	NULL
20	NULL
200	NULL
20	NULL
50	NULL
100	NULL
200	NULL
m	NULL
s	NULL
sme	NULL
f	NULL
£	NULL
Lt	NULL
1:2	NULL
3	NULL
4	NULL
5	NULL
°°06	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Oxidoreductive	NULL
modulations	NULL
of	NULL
the	NULL
cytosolic	NULL
NF	NULL
«	NULL
B	NULL
with	NULL
its	NULL
natural	NULL
redox	NULL
status	NULL
.	NULL

A	NULL
,	NULL
the	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
in	NULL
fractions	NULL
from	NULL
the	NULL
glycerol	NULL
density	NULL
gradient	NULL
centrifugation	NULL
prepared	NULL
with	NULL
buffers	NULL
deaerated	NULL
and	NULL
replaced	NULL
by	NULL
nitrogen	NULL
gas	NULL
.	NULL

Each	NULL
cytosolic	NULL
fraction	NULL
was	NULL
first	NULL
treated	NULL
by	NULL
the	NULL
detergents	NULL
to	NULL
dissociate	NULL
IxB	NULL
before	NULL
reduction	NULL
by	NULL
the	NULL
Trx	NULL
system	NULL
.	NULL

In	NULL
even	NULL
numbered	NULL
lanes	NULL
,	NULL
the	NULL
cytosolic	NULL
NFx	NULL
«	NULL
B	NULL
was	NULL
reduced	NULL
by	NULL
the	NULL
Trx	NULL
system	NULL
(	NULL
+	NULL
)	NULL
;	NULL
in	NULL
odd	NULL
numbered	NULL
lanes	NULL
,	NULL
it	NULL
was	NULL
not	NULL
reduced	NULL
(	NULL
-	NULL
)	NULL
.	NULL

The	NULL
closed	NULL
triangle	NULL
indicates	NULL
the	NULL
NFxB-DNA	NULL
complex	NULL
,	NULL
and	NULL
the	NULL
open	NULL
triangle	NULL
indicates	NULL
the	NULL
free	NULL
probe	NULL
.	NULL

B	NULL
,	NULL
comparison	NULL
of	NULL
reducing	NULL
activities	NULL
of	NULL
various	NULL
reductants	NULL
in	NULL
activating	NULL
the	NULL
cytosolic	NULL
NF	NULL
«	NULL
B	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
examined	NULL
by	NULL
EMSA	NULL
.	NULL

Reduction	NULL
with	NULL
the	NULL
Trx	NULL
system	NULL
or	NULL
the	NULL
glutathione	NULL
(	NULL
GSH	NULL
)	NULL
system	NULL
was	NULL
performed	NULL
at	NULL
30	NULL
°C	NULL
for	NULL
5	NULL
min	NULL
.	NULL

Lanes	NULL
2-12	NULL
,	NULL
cytosolic	NULL
fraction	NULL
2	NULL
was	NULL
first	NULL
treated	NULL
by	NULL
the	NULL
detergents	NULL
to	NULL
dissociate	NULL
IxB	NULL
from	NULL
the	NULL
NFxB	NULL
-I	NULL
«	NULL
xB	NULL
complex	NULL
and	NULL
then	NULL
various	NULL
reductants	NULL
were	NULL
added	NULL
:	NULL
no	NULL
reductant	NULL
added	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
10	NULL
mM	NULL
DTT	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
20	NULL
mm	NULL
2-ME	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
full	NULL
component	NULL
of	NULL
Trx	NULL
system	NULL
with	NULL
20	NULL
uM	NULL
Trx	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
with	NULL
20	NULL
uM	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
fully	NULL
reduced	NULL
GSH	NULL
(	NULL
lane	NULL
7	NULL
,	NULL
20	NULL
um	NULL
;	NULL
lane	NULL
8	NULL
,	NULL
200	NULL
um	NULL
)	NULL
,	NULL
full	NULL
component	NULL
of	NULL
GSH	NULL
system	NULL
Redox	NULL
Regulation	NULL
of	NULL
NFB	NULL
strated	NULL
that	NULL
effects	NULL
of	NULL
the	NULL
cotransfection	NULL
of	NULL
T'rx	NULL
(	NULL
ADF	NULL
)	NULL
-expres-sion	NULL
plasmid	NULL
are	NULL
dependent	NULL
on	NULL
the	NULL
«	NULL
B	NULL
sequence	NULL
within	NULL
the	NULL
reporter	NULL
plasmid	NULL
,	NULL
which	NULL
supports	NULL
our	NULL
present	NULL
findings	NULL
.	NULL

In	NULL
vitro	NULL
biochemical	NULL
analyses	NULL
were	NULL
able	NULL
to	NULL
dissect	NULL
this	NULL
phenomenon	NULL
in	NULL
greater	NULL
detail	NULL
and	NULL
revealed	NULL
that	NULL
redox	NULL
regulation	NULL
of	NULL
NFxB	NULL
activity	NULL
appeared	NULL
to	NULL
be	NULL
exerted	NULL
after	NULL
dissociation	NULL
of	NULL
IxB	NULL
from	NULL
NFxB	NULL
.	NULL

These	NULL
findings	NULL
not	NULL
only	NULL
demonstrate	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
novel	NULL
modality	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
NFxB-mediated	NULL
gene	NULL
expression	NULL
,	NULL
but	NULL
also	NULL
provide	NULL
evidence	NULL
that	NULL
cysteine	NULL
residue	NULL
(	NULL
s	NULL
)	NULL
on	NULL
NFxB	NULL
might	NULL
be	NULL
involved	NULL
in	NULL
its	NULL
interaction	NULL
with	NULL
the	NULL
target	NULL
DNA	NULL
sequence	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
attempted	NULL
to	NULL
clarify	NULL
in	NULL
greater	NULL
detail	NULL
how	NULL
Trx	NULL
regulates	NULL
NFxB	NULL
.	NULL

We	NULL
prepared	NULL
the	NULL
cytosolic	NULL
NF	NULL
«	NULL
B/	NULL
I	NULL
«	NULL
B	NULL
from	NULL
primary	NULL
human	NULL
lymphocytes	NULL
because	NULL
cell	NULL
lines	NULL
are	NULL
considered	NULL
to	NULL
have	NULL
wide	NULL
variety	NULL
of	NULL
differences	NULL
in	NULL
the	NULL
responsiveness	NULL
to	NULL
oxidoreductive	NULL
reagents	NULL
that	NULL
might	NULL
have	NULL
evolved	NULL
during	NULL
long	NULL
term	NULL
culture	NULL
.	NULL

We	NULL
have	NULL
demonstrated	NULL
evidence	NULL
suggesting	NULL
that	NULL
the	NULL
redox	NULL
regulation	NULL
of	NULL
NFxB	NULL
by	NULL
Trx	NULL
might	NULL
be	NULL
exerted	NULL
after	NULL
the	NULL
dissociation	NULL
of	NULL
IxB	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
prepared	NULL
the	NULL
cytosolic	NULL
NFxB	NULL
retaining	NULL
the	NULL
redox	NULL
status	NULL
of	NULL
the	NULL
cells	NULL
in	NULL
culture	NULL
without	NULL
using	NULL
artificial	NULL
reductants	NULL
and	NULL
found	NULL
that	NULL
the	NULL
cytosolic	NULL
NF	NULL
«	NULL
B	NULL
might	NULL
require	NULL
further	NULL
reduction	NULL
to	NULL
acquire	NULL
its	NULL
full	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

This	NULL
in	NULL
vitro	NULL
observation	NULL
could	NULL
explain	NULL
why	NULL
gene	NULL
expression	NULL
from	NULL
HIV	NULL
LTR	NULL
can	NULL
be	NULL
activated	NULL
solely	NULL
by	NULL
the	NULL
co-transfection	NULL
of	NULL
the	NULL
Trx-expressing	NULL
plasmid	NULL
(	NULL
this	NULL
study	NULL
;	NULL
Matthews	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

We	NULL
also	NULL
found	NULL
that	NULL
among	NULL
various	NULL
reductants	NULL
,	NULL
either	NULL
physiological	NULL
or	NULL
artificial	NULL
,	NULL
Trx	NULL
showed	NULL
the	NULL
greatest	NULL
effect	NULL
in	NULL
activating	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF	NULL
«	NULL
xB	NULL
.	NULL

These	NULL
observations	NULL
support	NULL
the	NULL
possibility	NULL
that	NULL
a	NULL
cellular	NULL
redox	NULL
control	NULL
system	NULL
such	NULL
as	NULL
Trx	NULL
has	NULL
a	NULL
regulatory	NULL
role	NULL
in	NULL
controlling	NULL
the	NULL
activity	NULL
of	NULL
NFxB	NULL
.	NULL

The	NULL
present	NULL
observations	NULL
raise	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
redox	NULL
reactive	NULL
cysteine	NULL
(	NULL
s	NULL
)	NULL
in	NULL
the	NULL
DNA-binding	NULL
by	NULL
NFxB	NULL
.	NULL

Fig	NULL
.	NULL

7A	NULL
illustrates	NULL
the	NULL
amino	NULL
acid	NULL
sequence	NULL
alignment	NULL
of	NULL
the	NULL
putative	NULL
DNA-binding	NULL
domain	NULL
,	NULL
or	NULL
NRD	NULL
domain	NULL
(	NULL
Henkel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
,	NULL
of	NULL
the	NULL
members	NULL
of	NULL
the	NULL
rel	NULL
oncogene	NULL
family	NULL
.	NULL

Among	NULL
the	NULL
amino	NULL
acid	NULL
residues	NULL
,	NULL
3	NULL
cysteines	NULL
within	NULL
this	NULL
region	NULL
(	NULL
amino	NULL
acid	NULL
positions	NULL
62	NULL
,	NULL
119	NULL
,	NULL
and	NULL
273	NULL
in	NULL
p50	NULL
)	NULL
are	NULL
conserved	NULL
.	NULL

We	NULL
then	NULL
attempted	NULL
to	NULL
locate	NULL
the	NULL
specific	NULL
target	NULL
cysteine	NULL
by	NULL
inspecting	NULL
the	NULL
electrostatic	NULL
microenvironment	NULL
of	NULL
each	NULL
cysteine	NULL
,	NULL
since	NULL
it	NULL
was	NULL
indicated	NULL
that	NULL
the	NULL
reactivity	NULL
of	NULL
a	NULL
cysteine	NULL
was	NULL
enhanced	NULL
by	NULL
the	NULL
neighboring	NULL
basic	NULL
amino	NULL
acids	NULL
through	NULL
formation	NULL
of	NULL
a	NULL
thiol-anion	NULL
base	NULL
pair	NULL
(	NULL
Kallis	NULL
and	NULL
Holmgren	NULL
,	NULL
1980	NULL
;	NULL
Snyder	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1981	NULL
)	NULL
.	NULL

The	NULL
cysteine	NULL
at	NULL
amino	NULL
acid	NULL
position	NULL
62	NULL
in	NULL
p50	NULL
appeared	NULL
to	NULL
have	NULL
the	NULL
most	NULL
and	NULL
the	NULL
only	NULL
basic	NULL
environment	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7B	NULL
and	NULL
was	NULL
considered	NULL
to	NULL
be	NULL
the	NULL
target	NULL
of	NULL
the	NULL
redox	NULL
regulation	NULL
(	NULL
see	NULL
also	NULL
Mathews	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
)	NULL
.	NULL

In	NULL
apparent	NULL
contrast	NULL
to	NULL
our	NULL
observations	NULL
demonstrating	NULL
the	NULL
potentiation	NULL
of	NULL
NFB	NULL
binding	NULL
by	NULL
reducing	NULL
agents	NULL
,	NULL
several	NULL
groups	NULL
have	NULL
reported	NULL
that	NULL
the	NULL
TNF-mediated	NULL
NFxB-depend-ent	NULL
activation	NULL
of	NULL
gene	NULL
expression	NULL
from	NULL
the	NULL
HIV-1	NULL
LTR	NULL
in	NULL
intact	NULL
cells	NULL
was	NULL
efficiently	NULL
inhibited	NULL
by	NULL
treating	NULL
the	NULL
cells	NULL
with	NULL
N-acetylcysteine	NULL
(	NULL
NAC	NULL
)	NULL
,	NULL
a	NULL
precursor	NULL
for	NULL
GSH	NULL
,	NULL
or	NULL
another	NULL
thiol	NULL
compound	NULL
pyrrolidone	NULL
derivative	NULL
of	NULL
dithiocarbamate	NULL
(	NULL
Staal	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Roederer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Schreck	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Since	NULL
GSH	NULL
even	NULL
with	NULL
a	NULL
higher	NULL
concentration	NULL
did	NULL
not	NULL
restore	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
diamide-oxidized	NULL
NFxB	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
NAC	NULL
could	NULL
not	NULL
be	NULL
ascribed	NULL
to	NULL
its	NULL
reducing	NULL
activity	NULL
but	NULL
to	NULL
the	NULL
indirect	NULL
effects	NULL
on	NULL
other	NULL
cellular	NULL
reducing	NULL
system	NULL
such	NULL
as	NULL
the	NULL
Trx	NULL
system	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
found	NULL
that	NULL
the	NULL
amount	NULL
of	NULL
Trx	NULL
is	NULL
greatly	NULL
increased	NULL
in	NULL
primary	NULL
lymphocytes	NULL
and	NULL
T-cell	NULL
lines	NULL
by	NULL
treatment	NULL
with	NULL
hydrogen	NULL
peroxide	NULL
or	NULL
TNF	NULL
and	NULL
that	NULL
pretreatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
NAC	NULL
prohibits	NULL
the	NULL
induction	NULL
with	NULL
GSH	NULL
concentrations	NULL
of	NULL
20	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
,	NULL
50	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
,	NULL
100	NULL
(	NULL
lane	NULL
11	NULL
)	NULL
,	NULL
and	NULL
200	NULL
um	NULL
(	NULL
lane	NULL
12	NULL
)	NULL
.	NULL

Redox	NULL
Regulation	NULL
of	NULL
NFxB	NULL
A	NULL
HIV-1	NULL
LTR	NULL
U	NULL
3	NULL
R	NULL
U	NULL
S	NULL
weati	NULL
09	NULL
``	NULL
wiegg	NULL
Spr	NULL
NF	NULL
HIV-1	NULL
(	NULL
wt	NULL
)	NULL
CAT	NULL
,	NULL
HIV-1	NULL
(	NULL
xBmut	NULL
}	NULL
CAT	NULL
B	NULL
(	NULL
COS-1	NULL
)	NULL
HIV-1	NULL
(	NULL
wt	NULL
)	NULL
CAT	NULL
HIV-1	NULL
(	NULL
xBmut	NULL
)	NULL
CAT	NULL
15	NULL
2	NULL
#	NULL
2	NULL
2	NULL
3	NULL
210	NULL
i	NULL
i	NULL
5	NULL
5	NULL
3	NULL
3	NULL
$	NULL
$	NULL
5	NULL
a	NULL
aC	NULL
4	NULL
24	NULL
36	NULL
48	NULL
60	NULL
24	NULL
36	NULL
48	NULL
60	NULL
Hours	NULL
After	NULL
Transfection	NULL
Hours	NULL
After	NULL
Transfection	NULL
C	NULL
(	NULL
Jurkat	NULL
)	NULL
HIV-1	NULL
(	NULL
wi	NULL
)	NULL
CAT	NULL
HIV-1	NULL
(	NULL
xBmut	NULL
)	NULL
CAT	NULL
5	NULL
5	NULL
a	NULL
4	NULL
a	NULL
4	NULL
9	NULL
9	NULL
R	NULL
3	NULL
c	NULL
3	NULL
<	NULL
<	NULL
0	NULL
(	NULL
)	NULL
$	NULL
2	NULL
$	NULL
2	NULL
el	NULL
s	NULL
9	NULL
9	NULL
C	NULL
&	NULL
-s	NULL
all	NULL
24	NULL
36	NULL
48	NULL
60	NULL
Hours	NULL
After	NULL
Transfection	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Augmentation	NULL
of	NULL
gene	NULL
expression	NULL
from	NULL
HIV-1	NULL
LTR	NULL
by	NULL
co-transfection	NULL
of	NULL
Trx	NULL
gene	NULL
:	NULL
evidence	NULL
of	NULL
redox	NULL
regulation	NULL
in	NULL
intact	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
schematic	NULL
diagrams	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR-driven	NULL
CAT	NULL
plasmids	NULL
.	NULL

Cis-regulatory	NULL
elements	NULL
within	NULL
the	NULL
HIV-1	NULL
LTR	NULL
are	NULL
shown	NULL
.	NULL

In	NULL
the	NULL
mutant	NULL
(	NULL
xBmut	NULL
)	NULL
,	NULL
each	NULL
copy	NULL
of	NULL
the	NULL
tandemly	NULL
repeated	NULL
xB	NULL
sequence	NULL
was	NULL
replaced	NULL
by	NULL
the	NULL
NFB	NULL
nonbinding	NULL
sequence	NULL
.	NULL

B	NULL
and	NULL
C	NULL
,	NULL
results	NULL
of	NULL
CAT	NULL
assays	NULL
with	NULL
the	NULL
HIV-1	NULL
LTR-CAT	NULL
constructs	NULL
in	NULL
COS-1	NULL
(	NULL
B	NULL
)	NULL
and	NULL
Jurkat	NULL
(	NULL
C	NULL
)	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
reporter	NULL
plasmid	NULL
in	NULL
combination	NULL
with	NULL
either	NULL
SRaADF	NULL
or	NULL
the	NULL
control	NULL
plasmid	NULL
.	NULL

SRaADF	NULL
is	NULL
an	NULL
effector	NULL
plasmid	NULL
that	NULL
expresses	NULL
human	NULL
Trx	NULL
(	NULL
also	NULL
known	NULL
as	NULL
ADF	NULL
)	NULL
(	NULL
Tagaya	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

The	NULL
numbers	NULL
indicated	NULL
below	NULL
each	NULL
lane	NULL
are	NULL
the	NULL
time	NULL
(	NULL
in	NULL
hours	NULL
)	NULL
of	NULL
cell	NULL
harvest	NULL
after	NULL
the	NULL
medium	NULL
change	NULL
following	NULL
transfection	NULL
.	NULL

A	NULL
fixed	NULL
amount	NULL
(	NULL
70	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
of	NULL
cell	NULL
lysate	NULL
was	NULL
used	NULL
for	NULL
CAT	NULL
enzyme	NULL
assays	NULL
.	NULL

The	NULL
efficiency	NULL
of	NULL
transfection	NULL
was	NULL
monitored	NULL
by	NULL
co-transfection	NULL
of	NULL
A-galactosidase	NULL
expression	NULL
plasmid	NULL
under	NULL
the	NULL
control	NULL
of	NULL
RSV	NULL
LTR	NULL
.	NULL

24	NULL
36	NULL
48	NULL
60	NULL
Hours	NULL
After	NULL
Transfection	NULL
of	NULL
Tx	NULL
production	NULL
upon	NULL
such	NULL
treatment	NULL
.	NULL
``	NULL

Transient	NULL
oxidative	NULL
stress	NULL
within	NULL
the	NULL
cells	NULL
elicited	NULL
by	NULL
hydrogen	NULL
peroxide	NULL
,	NULL
TNF	NULL
or	NULL
others	NULL
,	NULL
might	NULL
induce	NULL
the	NULL
production	NULL
of	NULL
Trx	NULL
and	NULL
the	NULL
induced	NULL
Trx	NULL
would	NULL
then	NULL
activate	NULL
NF	NULL
«	NULL
B	NULL
that	NULL
had	NULL
been	NULL
oxidized	NULL
by	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
(	NULL
which	NULL
probably	NULL
dissociates	NULL
IxB	NULL
by	NULL
either	NULL
a	NULL
direct	NULL
or	NULL
indirect	NULL
mechanism	NULL
at	NULL
the	NULL
same	NULL
time	NULL
)	NULL
.	NULL

*	NULL
T.	NULL
Okamoto	NULL
,	NULL
T.	NULL
Masutani	NULL
,	NULL
T.	NULL
Hayashi	NULL
,	NULL
and	NULL
J.	NULL
Yodoi	NULL
,	NULL
manuscript	NULL
in	NULL
preparation	NULL
.	NULL

11387	NULL
A	NULL
=	NULL
.	NULL

57	NULL
p50	NULL
<	NULL
>	NULL
>	NULL
RPRY	NULL
VBEGPSHGGLPGA-SS-EXNKKSY	NULL
PQVK	NULL
ICNYVGPAKY	NULL
I	NULL
VQLVTNG-	NULL
KN	NULL
p65	NULL
<	NULL
+	NULL
»	NULL
RPRY	NULL
IRRGRSAGS	NULL
I	NULL
PGE-RS-TDTTKTHPT	NULL
IX	NULL
INGYTGPGTVR	NULL
1	NULL
SLVTKD-PP	NULL
£49/p100	NULL
.	NULL

>	NULL
>	NULL
RFRY	NULL
PSHGGLPGE-SS-ERXGRLTF	NULL
PTVE	NULL
I	NULL
CNYEGPAK	NULL
I	NULL
EVDLVTHS-DP	NULL
corel	NULL
<	NULL
+	NULL
>	NULL
RFRYOBECRSAGSI	NULL
PQE-HS-TDNNRTY	NULL
PS	NULL
I	NULL
NTMRYYGRGKVR	NULL
T	NULL
TLVTXN-DP	NULL
dorsal	NULL
<	NULL
+	NULL
+	NULL
RERYBOECRSAGS1	NULL
PGVNSTPE-	NULL
NK~TYPT	NULL
1	NULL
EIVGYXG	NULL
--	NULL
RAVY	NULL
«	NULL
VUSCVTR	NULL
D	NULL
107	NULL
p50	NULL
1	NULL
HL-	NULL
EDG	NULL
ICTYTAGPKD-M-	NULL
YVGFANLA	NULL
]	NULL
LAVTKKKYFET	NULL
p65	NULL
HRP	NULL
-	NULL
RDGFYEARLCPDR-C-	NULL
I	NULL
HSFQNLG	NULL
I	NULL
QOVKXRDLEQA	NULL
p49/p100	NULL
PRA	NULL
--	NULL
1	NULL
CAVSYGPKD	NULL
-M-	NULL
T	NULL
AQFNNLGY	NULL
LVT	NULL
KKNHGT	NULL
corel	NULL
YKP~	NULL
-	NULL
HPHDLVGKD-EF	NULL
RDG	NULL
FFEAEFOGNER-R	NULL
-PLFFQNLG	NULL
I	NULL
ROVKKKEVKEA	NULL
dorsal	NULL
TPYRPHPHNLNGK	NULL
EGG	NULL
:	NULL
KXGYCTLE	NULL
INS-ETMRAY-	NULL
FSNLG	NULL
I	NULL
QQV-	NULL
KKK	NULL
-	NULL
-D-154	NULL
p50	NULL
LEARK~-~	NULL
--	NULL
-	NULL
=-	NULL
TEACIRGYNPGLLYHPDLAYLQAEGGG	NULL
-DRQLCDRE	NULL
p65	NULL
SQR	NULL
[	NULL
--	NULL
-	NULL
~-	NULL
QTNNNPRQ-	NULL
-n	NULL
cnn	NULL
YPIEEQRGDY	NULL
p49/p100	NULL
HIQKLQRQRLRSRPQGLTEA	NULL
--	NULL
--	NULL
--	NULL
=~	NULL
--	NULL
E-QRELEQEA	NULL
corel	NULL
TRI	NULL
KAGINPRN	NULL
--	NULL
=	NULL
nne	NULL
VP-IXQLNDIE	NULL
dorsal	NULL
n	NULL
=s	NULL
LKARBE	NULL
-	NULL
R-	NULL
<	NULL
<	NULL
--	NULL
194	NULL
p50	NULL
KEL	NULL
IRQAALQQTKEMDL-SVVRLMFTARLPDST~-CSRTRRLEPVYSDA	NULL
I	NULL
YDS	NULL
-	NULL
nnn	NULL
OL	NULL
.	NULL

-NAVRLCRQUT	NULL
VROPS	NULL
--	NULL
GRP-LRLPPYLPHP	NULL
T	NULL
FDN	NULL
p49/p100	NULL
KEL	NULL
--	NULL
~	NULL
I	NULL
VRLRPSAF	NULL
LRASD-	NULL
-CSPSLPLKPVTSQPLHDS	NULL
e-reb	NULL
.	NULL

ners	NULL
DCDL-NYVRLCRQVRLPDEE-	NULL
-GNLTTALPPVVSNP	NULL
L	NULL
YDN	NULL
dorsal	NULL
RF	NULL
--	NULL
-QPS	NULL
--	NULL
~§	NULL
--	NULL
LDLNSY-RLCFQUPH	NULL
-	NULL
ESEQKGRRTSPLPPVUSEPI	NULL
PDK	NULL
244	NULL
285	NULL
p50	NULL
KAPNASNLK	NULL
I	NULL
Y	NULL
-RHDRTAGC	NULL
-	NULL
VTG-GBE	NULL
-	NULL
I	NULL
YLLEDKVQKDDIQ1	NULL
R	NULL
:	NULL
>	NULL
p6a	NULL
RAPNTAELKIC-RVNRNSGS-CLG-GDE	NULL
-	NULL
(	NULL
FLLEDKYQKEDIEVY	NULL
>	NULL
p49/p100	NULL
KSPGASNLK	NULL
1S-RMDKTAGS-VRG-GDE	NULL
-	NULL
V¥LLODK	NULL
YQKDD	NULL
LEVER	NULL
:	NULL
+-c-rel	NULL
RAPNTABLRIC-	NULL
RYNKNCGS	NULL
-	NULL
VRG-GDE	NULL
-	NULL
I	NULL
PLUPDK	NULL
YQKDDI	NULL
EVR	NULL
-	NULL
-	NULL
dorsa	NULL
l	NULL
KA	NULL
--	NULL
MSDLYLC-RLC-S	NULL
--	NULL
CSATVEGNTQI	NULL
I	NULL
:	NULL
-	NULL
local	NULL
pI	NULL
62	NULL
RFRYV	NULL
CE	NULL
GP	NULL
S	NULL
II	NULL
9.1	NULL
+o	NULL
+	NULL
-	NULL
+	NULL
119	NULL
L	NULL
VGKHGEDGIC	NULL
5.2	NULL
++	NULL
273	NULL
E	NULL
I1	NULL
YL	NULL
L	NULL
€DKV	NULL
Q	NULL
K	NULL
6.2	NULL
-	NULL
-+	NULL
+	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Putative	NULL
target	NULL
cysteine	NULL
in	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NFB	NULL
for	NULL
redox	NULL
regulation	NULL
.	NULL

A	NULL
,	NULL
amino	NULL
acid	NULL
sequence	NULL
homology	NULL
in	NULL
the	NULL
DNA-binding	NULL
domains	NULL
among	NULL
the	NULL
members	NULL
of	NULL
rel	NULL
oncogene	NULL
family	NULL
.	NULL

The	NULL
sequences	NULL
are	NULL
taken	NULL
from	NULL
human	NULL
p50	NULL
(	NULL
Kieran	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
p65	NULL
(	NULL
Ruben	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
p49/p100	NULL
(	NULL
Schmid	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
c-rel	NULL
(	NULL
Brownell	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
,	NULL
and	NULL
dorsal	NULL
(	NULL
Steward	NULL
,	NULL
1989	NULL
)	NULL
.	NULL

The	NULL
indicated	NULL
numbers	NULL
are	NULL
the	NULL
amino	NULL
acid	NULL
sequence	NULL
position	NULL
of	NULL
p50	NULL
subunit	NULL
of	NULL
NFkB	NULL
(	NULL
Kieran	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Positions	NULL
of	NULL
the	NULL
conserved	NULL
cysteines	NULL
(	NULL
or	NULL
histidines	NULL
)	NULL
are	NULL
marked	NULL
by	NULL
shadowed	NULL
boxes	NULL
.	NULL

B	NULL
,	NULL
locations	NULL
of	NULL
charged	NULL
amino	NULL
acids	NULL
and	NULL
estimated	NULL
isoelectric	NULL
points	NULL
(	NULL
local	NULL
pI	NULL
)	NULL
of	NULL
the	NULL
cysteine-containing	NULL
pep-tides	NULL
of	NULL
p50	NULL
.	NULL

The	NULL
pI	NULL
value	NULL
was	NULL
calculated	NULL
with	NULL
each	NULL
11	NULL
amino	NULL
acids	NULL
sequence	NULL
described	NULL
here	NULL
.	NULL

Both	NULL
positively	NULL
and	NULL
negatively	NULL
charged	NULL
amino	NULL
acids	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
large	NULL
amount	NULL
of	NULL
oxygen	NULL
scavengers	NULL
such	NULL
as	NULL
GSH	NULL
might	NULL
block	NULL
the	NULL
induction	NULL
of	NULL
Trx	NULL
by	NULL
neutralizing	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
and	NULL
thus	NULL
could	NULL
intervene	NULL
the	NULL
activation	NULL
of	NULL
NFxB	NULL
.	NULL

Additionally	NULL
,	NULL
the	NULL
results	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
indicated	NULL
that	NULL
the	NULL
cytosolic	NULL
NFB	NULL
might	NULL
need	NULL
to	NULL
be	NULL
reduced	NULL
to	NULL
acquire	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

It	NULL
is	NULL
,	NULL
therefore	NULL
,	NULL
suggested	NULL
that	NULL
the	NULL
PKC	NULL
cascade	NULL
might	NULL
also	NULL
stimulate	NULL
cellular	NULL
reducing	NULL
system	NULL
such	NULL
as	NULL
Trx	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
by	NULL
the	NULL
redox	NULL
control	NULL
mechanism	NULL
is	NULL
also	NULL
known	NULL
for	NULL
Fos-Jun	NULL
DNA	NULL
interaction	NULL
(	NULL
Abate	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Xanthoudakis	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
have	NULL
recently	NULL
identified	NULL
Ref-1	NULL
protein	NULL
as	NULL
a	NULL
cellular	NULL
reductant	NULL
.	NULL

They	NULL
have	NULL
shown	NULL
that	NULL
Ref-1	NULL
stimulates	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
some	NULL
other	NULL
transcription	NULL
factor	NULL
.	NULL

However	NULL
,	NULL
considering	NULL
the	NULL
relatively	NULL
low	NULL
efficiency	NULL
of	NULL
Ref-1	NULL
on	NULL
reducing	NULL
NF	NULL
«	NULL
B	NULL
(	NULL
Xan-thoudakis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
Ref-1	NULL
has	NULL
a	NULL
major	NULL
role	NULL
in	NULL
the	NULL
redox	NULL
regulation	NULL
of	NULL
NF	NULL
«	NULL
B	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
various	NULL
intracellular	NULL
reductants	NULL
might	NULL
have	NULL
differential	NULL
roles	NULL
in	NULL
the	NULL
redox	NULL
regulation	NULL
of	NULL
various	NULL
target	NULL
proteins	NULL
.	NULL

Redox	NULL
regulation	NULL
is	NULL
intrinsic	NULL
for	NULL
cells	NULL
,	NULL
especially	NULL
for	NULL
lymphocytes	NULL
and	NULL
macrophages	NULL
(	NULL
reviewed	NULL
by	NULL
Ziegler	NULL
(	NULL
1985	NULL
)	NULL
,	NULL
Holm-	NULL
11388	NULL
gren	NULL
(	NULL
1989	NULL
)	NULL
,	NULL
and	NULL
Liebermann	NULL
and	NULL
Baltimore	NULL
(	NULL
1990	NULL
)	NULL
)	NULL
.	NULL

These	NULL
cells	NULL
appear	NULL
to	NULL
utilize	NULL
this	NULL
metabolic	NULL
pathway	NULL
in	NULL
responding	NULL
to	NULL
the	NULL
various	NULL
extracellular	NULL
stimuli	NULL
,	NULL
including	NULL
those	NULL
elicited	NULL
during	NULL
cell-cell	NULL
communication	NULL
or	NULL
by	NULL
infection	NULL
with	NULL
microbes	NULL
.	NULL

Although	NULL
the	NULL
ability	NULL
of	NULL
NF	NULL
«	NULL
B	NULL
to	NULL
respond	NULL
to	NULL
the	NULL
cellular	NULL
redox	NULL
status	NULL
may	NULL
not	NULL
be	NULL
unique	NULL
to	NULL
this	NULL
protein	NULL
,	NULL
regulation	NULL
of	NULL
HIV	NULL
replication	NULL
through	NULL
NF	NULL
«	NULL
B	NULL
appears	NULL
to	NULL
endow	NULL
this	NULL
virus	NULL
with	NULL
various	NULL
biological	NULL
features	NULL
that	NULL
are	NULL
probably	NULL
favorable	NULL
for	NULL
its	NULL
life	NULL
cycle	NULL
during	NULL
disease	NULL
progression	NULL
and	NULL
for	NULL
the	NULL
virus	NULL
spread	NULL
.	NULL

HIV	NULL
may	NULL
have	NULL
acquired	NULL
the	NULL
responsiveness	NULL
to	NULL
NFxB	NULL
through	NULL
mutations	NULL
and	NULL
selections	NULL
of	NULL
the	NULL
LTR	NULL
sequence	NULL
before	NULL
it	NULL
becomes	NULL
fully	NULL
pathogenic	NULL
.	NULL

Indeed	NULL
,	NULL
accumulation	NULL
of	NULL
oxidative	NULL
stress	NULL
in	NULL
the	NULL
HIV-infected	NULL
individuals	NULL
has	NULL
been	NULL
demonstrated	NULL
by	NULL
decreased	NULL
serum	NULL
and	NULL
cellular	NULL
glutathione	NULL
(	NULL
GSH	NULL
)	NULL
levels	NULL
(	NULL
Bub	NULL
!	NULL

et	NULL
al	NULL
.	NULL

,	NULL
1979	NULL
;	NULL
Roederer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
which	NULL
is	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
increasing	NULL
virus	NULL
load	NULL
and	NULL
the	NULL
elevated	NULL
TNF	NULL
level	NULL
(	NULL
Lahdevirta	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
pathological	NULL
processes	NULL
in	NULL
the	NULL
HIV-infected	NULL
individuals	NULL
may	NULL
be	NULL
linked	NULL
to	NULL
the	NULL
shift	NULL
of	NULL
the	NULL
redox	NULL
status	NULL
,	NULL
and	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
T'rx	NULL
level	NULL
is	NULL
elevated	NULL
although	NULL
it	NULL
is	NULL
yet	NULL
to	NULL
be	NULL
documented	NULL
.	NULL

In	NULL
view	NULL
of	NULL
therapeutic	NULL
interventions	NULL
,	NULL
one	NULL
can	NULL
envisage	NULL
the	NULL
application	NULL
of	NULL
reductants	NULL
,	NULL
such	NULL
as	NULL
NAC	NULL
and	NULL
other	NULL
thiol	NULL
com-pounds	NULL
,	NULL
to	NULL
restore	NULL
the	NULL
redox	NULL
status	NULL
to	NULL
prevent	NULL
AIDS	NULL
development	NULL
and	NULL
its	NULL
progression	NULL
.	NULL

It	NULL
remains	NULL
to	NULL
be	NULL
examined	NULL
whether	NULL
Trx	NULL
plays	NULL
a	NULL
part	NULL
in	NULL
disease	NULL
progression	NULL
in	NULL
vivo	NULL
and	NULL
whether	NULL
reversion	NULL
of	NULL
the	NULL
redox	NULL
status	NULL
is	NULL
effective	NULL
in	NULL
blocking	NULL
the	NULL
induction	NULL
of	NULL
T'rx	NULL
.	NULL

Acknowledgments-We	NULL
are	NULL
grateful	NULL
to	NULL
Dr.	NULL
Junji	NULL
Yodoi	NULL
for	NULL
encouragement	NULL
throughout	NULL
this	NULL
study	NULL
and	NULL
for	NULL
providing	NULL
SRaADF	NULL
plasmid	NULL
and	NULL
to	NULL
Dr.	NULL
Akira	NULL
Mitsui	NULL
for	NULL
helpful	NULL
comments	NULL
and	NULL
generous	NULL
gifts	NULL
of	NULL
recombinant	NULL
Trx	NULL
,	NULL
its	NULL
mutant	NULL
,	NULL
and	NULL
TxR	NULL
.	NULL

We	NULL
thank	NULL
Dr.	NULL
Teruaki	NULL
Sekine	NULL
for	NULL
help	NULL
in	NULL
cell	NULL
culture	NULL
and	NULL
cytofluorometric	NULL
analyses	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Drs	NULL
.	NULL

Tamiko	NULL
Kano-Sueoka	NULL
,	NULL
Hiroyuki	NULL
Kato	NULL
,	NULL
Urban	NULL
Ramstedt	NULL
,	NULL
and	NULL
William	NULL
Haseltine	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

Addendum-During	NULL
preparation	NULL
of	NULL
this	NULL
manuscript	NULL
,	NULL
Matthews	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
reported	NULL
the	NULL
results	NULL
of	NULL
site-directed	NULL
mutagenesis	NULL
of	NULL
putative	NULL
cysteines	NULL
and	NULL
concluded	NULL
that	NULL
cysteine	NULL
62	NULL
of	NULL
p50	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
redox	NULL
regulation	NULL
by	NULL
Trx	NULL
,	NULL
thus	NULL
confirming	NULL
our	NULL
consideration	NULL
here	NULL
.	NULL

REFERENCES	NULL
Abate	NULL
,	NULL
C.	NULL
,	NULL
Patel	NULL
,	NULL
L.	NULL
,	NULL
Rauscher	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
III	NULL
,	NULL
and	NULL
Curran	NULL
,	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
249	NULL
,	NULL
1157-1161	NULL
Bacuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

3	NULL
,	NULL
1689-1698	NULL
Bauskin	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
Alkalay	NULL
L	NULL
,	NULL
and	NULL
Ben-	NULL
Netiah	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Cell	NULL
66	NULL
685-696	NULL
Bohnlem	NULL
E.	NULL
,	NULL
Lowenthal	NULL
3	NULL
.	NULL

W.	NULL
,	NULL
Siekevitz	NULL
,	NULL
M	NULL
Franza	NULL
,	NULL
B.	NULL
R	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
53	NULL
,	NULL
827-836	NULL
Brownell	NULL
,	NULL
E.	NULL
,	NULL
Mittereder	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Rice	NULL
,	NULL
N.	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Oncogene	NULL
4	NULL
,	NULL
985-942	NULL
Buhl	NULL
,	NULL
R.	NULL
,	NULL
Holroyd	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
Mastrangeli	NULL
,	NULL
A.	NULL
,	NULL
Cantin	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Jaffe	NULL
,	NULL
H.	NULL
A.	NULL
,	NULL
Wells	NULL
,	NULL
F	NULL
B.	NULL
,	NULL
Saltini	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Crystal	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1979	NULL
)	NULL
Lancet	NULL
ii	NULL
,	NULL
1294-1296	NULL
Camusai	NULL
,	NULL
G.	NULL
,	NULL
Albano	NULL
,	NULL
E.	NULL
,	NULL
Tetta	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Bussolino	NULL
,	NULL
F.	NULL
(	NULL
1991	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
202	NULL
,	NULL
3-14	NULL
Cereghlm	NULL
S.	NULL
,	NULL
Blumenfeld	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Yaniv	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
2	NULL
,	NULL
957-974	NULL
Chen	NULL
,	NULL
C.	NULL
,	NULL
'and	NULL
Okayama	NULL
,	NULL
H.	NULL
(	NULL
1987	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
,	NULL
2745-2752	NULL
Cross	NULL
,	NULL
S.	NULL
L	NULL
Halden	NULL
,	NULL
N.	NULL
F.	NULL
,	NULL
Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Leonard	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Science	NULL
244	NULL
,	NULL
466—468	NULL
Dignam	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Lebovitz	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1489	NULL
Dmter	NULL
,	NULL
H.	NULL
,	NULL
Chiu	NULL
,	NULL
R.	NULL
,	NULL
Imagawa	NULL
,	NULL
M.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Jones	NULL
,	NULL
K.	NULL
A	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

6	NULL
,	NULL
4067	NULL
40	NULL
71	NULL
Ensoh	NULL
,	NULL
B.	NULL
,	NULL
Lusso	NULL
,	NULL
P.	NULL
,	NULL
Schachter	NULL
,	NULL
F.	NULL
,	NULL
Josephs	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
Rappaport	NULL
,	NULL
J.	NULL
,	NULL
Negro	NULL
,	NULL
F.	NULL
,	NULL
Gallo	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
and	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
.	NULL

J	NULL
.	NULL

8	NULL
,	NULL
3019-3027	NULL
Feuillard	NULL
,	NULL
J.	NULL
,	NULL
Gouy	NULL
,	NULL
H.	NULL
,	NULL
Bismuth	NULL
,	NULL
G.	NULL
,	NULL
Lee	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Debre	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Korner	NULL
,	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Cytokine	NULL
3	NULL
,	NULL
257-265	NULL
Redox	NULL
Regulation	NULL
of	NULL
NF	NULL
«	NULL
xB	NULL
Fiers	NULL
,	NULL
W.	NULL
(	NULL
1991	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

285	NULL
,	NULL
199-212	NULL
Gendelman	NULL
,	NULL
H.	NULL
E.	NULL
,	NULL
Phelps	NULL
,	NULL
W.	NULL
,	NULL
Fexgenbaum	NULL
L.	NULL
,	NULL
Ostrove	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Adachi	NULL
,	NULL
A.	NULL
,	NULL
Howley	NULL
,	NULL
P.	NULL
M.	NULL
Khoury	NULL
G.	NULL
,	NULL
Ginsb	NULL
erg	NULL
,	NULL
H.	NULL
S.	NULL
,	NULL
and	NULL
Mamn	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

83	NULL
9759-9763	NULL
Ghosh	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Baltlmore	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
344	NULL
,	NULL
678-682	NULL
Ghosh	NULL
S	NULL
Gifford	NULL
,	NULL
M	NULL
Riviere	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
Tempst	NULL
P.	NULL
,	NULL
Baltimore	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
1019	NULL
1029	NULL
Gilmore	NULL
,	NULL
T.	NULL
b	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
B41-843	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
Immunol	NULL
.	NULL

8	NULL
,	NULL
453-475	NULL
Hazan	NULL
,	NULL
U.	NULL
,	NULL
Thomas	NULL
,	NULL
D.	NULL
,	NULL
Alcami	NULL
,	NULL
J.	NULL
,	NULL
Bachelene	NULL
F.	NULL
,	NULL
Israel	NULL
,	NULL
N.	NULL
,	NULL
Yssel	NULL
,	NULL
H.	NULL
,	NULL
Virelizier	NULL
,	NULL
J.	NULL
L	NULL
and	NULL
Arenzana-	NULL
Sexsdedos	NULL
F.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
7861-	NULL
7865	NULL
Henkel	NULL
T.	NULL
,	NULL
Zabel	NULL
,	NULL
U.	NULL
,	NULL
Zee	NULL
,	NULL
K.	NULL
V.	NULL
,	NULL
Muller	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Fanning	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
CellS	NULL
1121	NULL
1133	NULL
Holmgren	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

54	NULL
,	NULL
237-271	NULL
Holmgren	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
13963-13966	NULL
Israel	NULL
,	NULL
N.	NULL
,	NULL
Hazan	NULL
,	NULL
U.	NULL
,	NULL
Alcami	NULL
,	NULL
J.	NULL
,	NULL
Mumer	NULL
Arenzana-Seisdedos	NULL
,	NULL
F.	NULL
,	NULL
Bachelerie	NULL
,	NULL
F.	NULL
,	NULL
Israel	NULL
A.	NULL
,	NULL
and	NULL
Vu'ehzler	NULL
J.	NULL
L.	NULL
(	NULL
1989	NULL
)	NULL
J	NULL
Immunol	NULL
.	NULL

148	NULL
,	NULL
3956-3960	NULL
Jamléeson	NULL
C	NULL
McCaffrey	NULL
,	NULL
.	NULL

,	NULL
Rao	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Sen	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
J	NULL
Immunol	NULL
.	NULL

147	NULL
,	NULL
416-420	NULL
Kallis	NULL
,	NULL
G.-B	NULL
.	NULL

,	NULL
and	NULL
Holmgren	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1980	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

255	NULL
,	NULL
10261-10265	NULL
Kawakami	NULL
,	NULL
K.	NULL
,	NULL
Scheidereit	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
4700-4704	NULL
Kieran	NULL
,	NULL
M.	NULL
,	NULL
Blank	NULL
V.	NULL
,	NULL
Logeat	NULL
,	NULL
F.	NULL
,	NULL
Vandekerckhove	NULL
,	NULL
J.	NULL
,	NULL
Lottspeich	NULL
,	NULL
F.	NULL
,	NULL
Le	NULL
Bail	NULL
,	NULL
O.	NULL
,	NULL
Urban	NULL
M.	NULL
B	NULL
Kounlsky	NULL
,	NULL
P	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
1007-	NULL
1018	NULL
Lahdevirta	NULL
,	NULL
J.	NULL
,	NULL
Maury	NULL
,	NULL
C.	NULL
P.	NULL
J.	NULL
,	NULL
Teppo	NULL
,	NULL
A.-M.	NULL
,	NULL
and	NULL
Repo	NULL
,	NULL
H.	NULL
(	NULL
1988	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

85	NULL
,	NULL
289-291	NULL
Lenardo	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
227-229	NULL
Libermann	NULL
,	NULL
T	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
2327-2334	NULL
Luthman	NULL
,	NULL
M	NULL
and	NULL
Holmgren	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
Biochemistry	NULL
21	NULL
,	NULL
6628-6633	NULL
Matthews	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Wakasugi	NULL
,	NULL
N.	NULL
,	NULL
Virelizier	NULL
,	NULL
J.-L.	NULL
,	NULL
Yodox	NULL
,	NULL
..	NULL
and	NULL
Hay	NULL
,	NULL
R.	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
20	NULL
,	NULL
(	NULL
3821-3830	NULL
Meichle	NULL
,	NULL
A.	NULL
,	NULL
Schutze	NULL
,	NULL
S.	NULL
,	NULL
Hensel	NULL
,	NULL
G.	NULL
,	NULL
Brunsing	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Kronke	NULL
,	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
8339-8343	NULL
Meyer	NULL
,	NULL
R.	NULL
,	NULL
Hatada	NULL
,	NULL
E.	NULL
N.	NULL
,	NULL
Hohmann	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
Haiker	NULL
,	NULL
M.	NULL
,	NULL
Bartsch	NULL
,	NULL
C.	NULL
,	NULL
Rothlis-berger	NULL
,	NULL
U	NULL
Lahm	NULL
H.	NULL
W	NULL
Schlaeger	NULL
E.	NULL
J.	NULL
,	NULL
Van	NULL
Loon	NULL
.	NULL

P.	NULL
,	NULL
and	NULL
Scheidereit	NULL
,	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
966-970	NULL
Mitsui	NULL
,	NULL
A.	NULL
,	NULL
Hirakawa	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Yodoi	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
chhem	NULL
Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

186	NULL
1220	NULL
1226	NULL
Mohtor	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
New	NULL
Biol	NULL
.	NULL

3	NULL
,	NULL
987-996	NULL
Mori	NULL
,	NULL
S	NULL
Takadﬂ	NULL
R.	NULL
,	NULL
Shlmotohno	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Okamoto	NULL
,	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
Jpn	NULL
.	NULL

J	NULL
Cancer	NULL
Res	NULL
.	NULL

81	NULL
1124-	NULL
1131	NULL
Nabel	NULL
,	NULL
G.	NULL
,	NULL
'and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Nature	NULL
326	NULL
,	NULL
711-713	NULL
Nabeslé	NULL
a.	NULL
J.	NULL
,	NULL
Rice	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Knipe	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
289	NULL
,	NULL
1288-1302	NULL
Okamoto	NULL
,	NULL
T	NULL
'	NULL
.	NULL

,	NULL
and	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
47	NULL
,	NULL
29-35	NULL
Okamoto	NULL
,	NULL
T.	NULL
,	NULL
Matsuyama	NULL
,	NULL
T	NULL
'	NULL
.	NULL

,	NULL
Mon	NULL
,	NULL
S.	NULL
,	NULL
Hamamoto	NULL
,	NULL
Y.	NULL
,	NULL
Kobayashi	NULL
,	NULL
N.	NULL
,	NULL
Yama-moto	NULL
,	NULL
N.	NULL
,	NULL
Josephs	NULL
S.	NULL
F.	NULL
,	NULL
Wong-Stan	NULL
]	NULL
F.	NULL
,	NULL
and	NULL
Shimotohno	NULL
,	NULL
K.	NULL
(	NULL
1989	NULL
)	NULL
AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retroviruses	NULL
5	NULL
,	NULL
131-138	NULL
Okamoto	NULL
,	NULL
T.	NULL
,	NULL
Benter	NULL
,	NULL
T.	NULL
,	NULL
Josephs	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
Sadaie	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
(	NULL
1990	NULL
)	NULL
Virology	NULL
177	NULL
,	NULL
606-614	NULL
Okamoto	NULL
,	NULL
T.	NULL
,	NULL
Ogiwara	NULL
,	NULL
H.	NULL
,	NULL
Hayashi	NULL
,	NULL
T.	NULL
,	NULL
Mitsui	NULL
,	NULL
A.	NULL
,	NULL
Kawabe	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Yodoi	NULL
,	NULL
T	NULL
(	NULL
1992	NULL
)	NULL
Int	NULL
.	NULL

``	NULL
Immunol	NULL
.	NULL

4	NULL
,	NULL
'8S11-819	NULL
Roederer	NULL
,	NULL
M.	NULL
,	NULL
Raju	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Staal	NULL
,	NULL
F.	NULL
J.	NULL
T.	NULL
,	NULL
Herzenberg	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
and	NULL
Herzenberg	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retroviruses	NULL
7	NULL
,	NULL
563-567	NULL
Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Dillon	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
Henkel	NULL
T.	NULL
,	NULL
Chen	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Maher	NULL
,	NULL
M.	NULL
,	NULL
Baeuerle	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Rosen	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Science	NULL
251	NULL
1490-1493	NULL
Schmid	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Perkins	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
Duckett	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
and	NULL
Nabel	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Nature	NULL
352	NULL
,	NULL
733-736	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
Rieber	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
.	NULL

J	NULL
10	NULL
,	NULL
2247-2258	NULL
Shuakawa	NULL
F	NULL
and	NULL
szel	NULL
S.	NULL
B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
2424-2430	NULL
Smith	NULL
,	NULL
K.	NULL
C	NULL
and	NULL
Aplin	NULL
,	NULL
R	NULL
T.	NULL
(	NULL
1966	NULL
)	NULL
Biochemistry	NULL
5	NULL
,	NULL
2125-2130	NULL
Snyder	NULL
,	NULL
G.	NULL
H.	NULL
,	NULL
Cennerazzo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Karalis	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
and	NULL
Field	NULL
,	NULL
D.	NULL
(	NULL
1981	NULL
)	NULL
Biochemistry	NULL
20	NULL
,	NULL
6509-6519	NULL
Staal	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
Roederer	NULL
,	NULL
M.	NULL
,	NULL
Herzenberg	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
and	NULL
Herzenberg	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
,	NULL
U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
9943-9947	NULL
Steward	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
59	NULL
,	NULL
1179-1188	NULL
Tagaya	NULL
,	NULL
Y	NULL
Maeda	NULL
,	NULL
Y.	NULL
,	NULL
M1tsu1	NULL
,	NULL
A	NULL
Kondo	NULL
,	NULL
N.	NULL
,	NULL
Matsui	NULL
,	NULL
H.	NULL
,	NULL
Hamuro	NULL
,	NULL
J.	NULL
,	NULL
Brown	NULL
,	NULL
N.	NULL
,	NULL
Aral	NULL
,	NULL
K..	NULL
Yokota	NULL
T.	NULL
,	NULL
Wakasugl	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Yodoi	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
757—764	NULL
Toledano	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
and	NULL
Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Prac	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
4328-4332	NULL
Tauboi	NULL
,	NULL
A.	NULL
,	NULL
Sugimoto	NULL
,	NULL
K.	NULL
,	NULL
Yodoi	NULL
,	NULL
J.	NULL
,	NULL
Miyatake	NULL
,	NULL
S.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Arai	NULL
,	NULL
N.	NULL
(	NULL
1991	NULL
)	NULL
Int	NULL
.	NULL

immunol	NULL
.	NULL

8	NULL
,	NULL
807-817	NULL
Urban	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1975-1984	NULL
Urban	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Baeuverle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
10	NULL
,	NULL
1817-1825	NULL
Wakasugl	NULL
,	NULL
N	NULL
Tagaya	NULL
,	NULL
Y.	NULL
,	NULL
Wakasugl	NULL
,	NULL
H.	NULL
,	NULL
Mitsui	NULL
,	NULL
A.	NULL
,	NULL
Maeda	NULL
,	NULL
M.	NULL
,	NULL
Yodm	NULL
,	NULL
J	NULL
.	NULL

,	NULL
and	NULL
Tursz	NULL
,	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
8282	NULL
8286	NULL
Wu	NULL
,	NULL
F.	NULL
K	NULL
Garcia	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Harrich	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Gaynor	NULL
,	NULL
R.	NULL
B	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

7	NULL
,	NULL
2117	NULL
2130	NULL
Xanthoudakis	NULL
,	NULL
S.	NULL
,	NULL
Miao	NULL
,	NULL
G.	NULL
,	NULL
Wang	NULL
,	NULL
F.	NULL
,	NULL
Pan	NULL
,	NULL
Y.-C.	NULL
E.	NULL
,	NULL
and	NULL
Curran	NULL
,	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

11	NULL
,	NULL
3323-3385	NULL
Zabel	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
61	NULL
,	NULL
255-265	NULL
Ziegler	NULL
,	NULL
D.	NULL
M.	NULL
(	NULL
1985	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

54	NULL
,	NULL
305-329	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
and	NULL

